GARY L. DUNBAR

CURRICULUM VITAE

CONTACT INFORMATION

CMU Office FNI Office Residence Health Professions Building 2182 4677 Towne Centre 2469 Copper Creek Drive Central Michigan University Suite 101 Bay City, MI 48706 Mt. Pleasant, MI 48859 Saginaw, MI 48604 (989) 280-2711 (989) 774-3282 (989) 497-3105 [email protected] [email protected]

EDUCATION

Bachelor of Arts Philosophy Florida Presbyterian (Eckerd) College Bachelor of Science Biopsychology Eckerd College Master of Arts Psychology Central Michigan University Master of Science Biology Central Michigan University Doctor of Philosophy Psychobiology Clark University

PROFESSIONAL EMPLOYMENT HISTORY

1987-1991 Assistant Professor/Department of Psychology Central Michigan University 1987-Present Director/Brain Research (now FNI) Laboratory Central Michigan University 1991-1995 Associate Professor/Department of Psychology Central Michigan University 1995-Present Professor/Department of Psychology Central Michigan University 1995-1999 Director/Experimental Psychology Program Central Michigan University 1999-Present Director/Program in Neuroscience Central Michigan University 2002-2005 Chair/Department of Psychology Central Michigan University 2003-Present Director/Brain Research and Integrative Neuroscience (BRAIN) Center Central Michigan University 2004-2005 Chair/Council of Chairs Central Michigan University 2008-Present Executive Director Field Neurosciences Institute

PROFESSIONAL HONORS

1991 Teaching Excellence Award, Central Michigan University 1996 Outstanding Teacher Award, College of Education, Health and Human Services, Central Michigan University 1997 Michigan Professor of the Year Award, Carnegie Foundation for the Advancement of Teaching and the Council for the Advancement and Support of Education 1997 Service Recognition Award, Faculty for Undergraduate Neuroscience. 1998 Distinguished Faculty Member Award, Michigan Association of Governing Boards of State Universities 1998 William H. Kadel Alumni Medal for Outstanding Career Achievement, Eckerd College. 1999 Service Excellence Award, Admissions Office, Central Michigan University 1999 Outstanding Service Award, Michigan Chapter of the Huntington’s Disease Society of America (received this award each year for the past 12 years). 2000 Best Paper Award, Midland Chapter, Sigma Xi, The Scientific Research Society 2002 Pioneer Award for Innovative Use of Technology, Central Michigan University 2003 Lifetime Achievement Award, Faculty for Undergraduate Neuroscience 2004 John G. Kulhavi Endowed Professorship in Neuroscience, Central Michigan University 2006 Faculty Distinguished Service Award, Central Michigan University 2011 Service Recognition Award, Editorial Board, Journal of Undergraduate Neuroscience Education 2011 President’s Award for Outstanding Research and Creative Endeavors, Central Michigan University 2012 E. Malcolm Field and Gary Leo Dunbar Endowed Chair in Neuroscience

PROFESSIONAL AFFILIATIONS

American Association for the Advancement of Science American Psychological Association American Psychological Society American Society for Neural Therapy and Repair European Brain and Behavior Society Faculty for Undergraduate Neuroscience Huntington Disease Society of America International Brain Research Organization Mind Association Michigan Chapter of the Society for Neuroscience Midwestern Psychological Association Philosophy of Science Association Sigma Xi, The Scientific Research Society Society for Neuroscience

ADMINISTRATIVE EXPERIENCE

1995-1999 Director, Graduate Program in Experimental Psychology

Responsibilities included serving on Departmental Executive Committee, which assisted Chairperson in scheduling classes, managing budgets, personnel decisions, and formulating departmental policies. Major accomplishments include the establishment of a new Ph.D. Program in Applied Experimental Psychology and adding 6 new assistantships and 2 new fellowships for the Experimental Psychology Program.

1999-Present Director, Program in Neuroscience

Responsible for establishing and overseeing the undergraduate neuroscience major (the first in the state of Michigan) and, subsequently, a MS and PhD program in neuroscience at CMU, forming and chairing the Advisory Committee and Neuroscience Council, crafting Bylaws for the Program, assist the dean in managing a $200,000/year operating budget, overseeing student advising in the Program, and running the seminar and directed research courses. Major accomplishments include expanding the program from six undergraduate majors to more than 200, adding 10 faculty positions to the program, successfully advocating for funding of at least eight graduate assistantships each year, and garnering technical and postdoctoral support for the program.

2002-2005 Chairperson, Department of Psychology

Responsibilities included managing a large department of 40 FTE, overseeing the discretionary (non-salary) portion of the $2 million annual operating budget, assigning teaching assignments, scheduling courses and classrooms, dealing with personnel and staff issues, administering departmental policies, and advocating for the advancement of the department. Major accomplishments included doubling the research space for faculty, reducing the teaching load from a 3-2 to a 2-2 for faculty who were productive researchers, assuring high quality research activity by implementing external review of scholarship, revision of departmental Bylaws, and facilitating a 47% increase in scholarly productivity and a 900% increase in external funding.

2003-Present Director, Brain Research and Integrative Neuroscience Center

Responsibilities include garnering funds and managing a supplies and equipment budget (ranging from $40,000 to $180,000) for the four-lab BRAIN Center, overseeing collaborative projects in the Center, ensuring proper use of the facilities, equipment, and animals, and garnering funding for the Center. Assist in designing and equipping our state-of-the-art core laboratories, behavioral testing, surgical, and animal care facilities and garnered grant monies to continually upgrade equipment needs for growing faculty and student demands.

2004-2005 Chairperson, Council of Chairs

Responsibilities included setting up biweekly meetings with the 30+ departmental chairs across the CMU campus, representing departmental chairs on key university committees, functioning as a liaison person in communications between the Council and the Provost, and establishing a new chair orientation program. Major accomplishments include chairing a successful “Special Emphasis” committee and preparing a completed report as part of the accreditation review for the Higher Learning Commission, assisting in the successful completion of Institutional Strategic Planning and University Vision documents, which helped establish the direction of CMU for the five year period between 2005-2010, and successful completion of the university budgetary process (a responsibility-management approach), including providing initial input in the establishment of the University Budget Allocation Committee, which oversees CMU’s budget.

2008-Present Executive Director, Field Neurosciences Institute.

Oversee all operations of the Institute, including educational (e.g., ThinkFirst, grand rounds, and various patient support groups), preclinical and clinical research programs, and fundraising programs; responsible for a $1million/year operating budget; develop collaborative relationships with other institutions (e.g., Central Michigan University, Saginaw Valley University, Henry Ford Hospital, Falk Institute at Northwestern University, University of California, Davis); direct strategic planning initiatives; report to the Board of Directors at Field Neurosciences Institute and at St. Mary’s of Michigan (with whom FNI is affiliated); serve on affiliated committees (e.g., FNI Finance Committee, FNI Research Committee, Institutional Review Board, Directors and Leadership Committees of St. Mary’s of Michigan). Significant accomplishments in the past five years include expanding the scope of our services, increasing research productivity by 500%, doubling our annual fundraising (from about $100k/year to around $200k/year), and increasing our total reserves from $3.3 million to over $7 million.

LEADERSHIP POSITIONS IN MAJOR ORGANIZATIONS

1994-1995 President, Faculty for Undergraduate Neuroscience

Responsibilities as the second president of this national organization was to coordinate the activities of all the various committees (e.g., education committee, student travel award committee, program committee, and faculty workshop committee), helped in fundraising and budget management, scheduled and chaired the annual meeting. Major accomplishments included helping to establish Bylaws, initiating procedures to attain tax-exempt status, instituting membership dues, soliciting corporate and institutional sponsorships, and helping to put the organization in a solid financial position to carry out its mission.

1998-2000 President, Michigan Chapter of the Society for Neuroscience

Responsibilities included setting up and chairing meetings of the Executive Committee, assisted in establishing the annual budget (approximately $20,000), assisted in planning and overseeing the annual meeting. Major accomplishments include the establishment of an Undergraduate Poster Award, initiating new memberships for Central Michigan University and Western Michigan University, increasing the number of vendors at the meeting, and bringing fiscal responsibility back to the organization (taking it from a deficit balance to a surplus).

2011-2012 Chairperson, Committee for Animal Research and Ethics, American Psychological Association (APA)

Responsible for updating guidelines and policies concerning the use of animals by APA members and providing input into new federal guidelines for animal care and use. Major accomplishments include: establishing new educational programs for both researchers and the general public on the need to judiciously use animals in research; updating existing APA literature on animal research and creating portable posters for presentations at major conferences and organizational meetings for which animal research issues are a concern.

2014-Present President, American Society for Neural Therapy and Repair

Responsible for overall supervision of this national organization, including overseeing committees for budget, publications (newsletters and website), grant submissions (for the organization), travel scholarships, memberships, and programs for annual meetings. Goals include expanding membership and student fellowships, increasing revenue, and establishing stronger ties with the International Society for Neural Therapy and Repair.

TEACHING AND MENTORING

Courses taught

Introductory Psychology 45 sections General Biology 1 section Mammalian Physiology 1 section Motivation and Emotion 1 section Physiological Psychology 8 sections Theories of Learning 1 section Statistics 2 sections *Behavioral Neuroscience 44 sections Experimental Psychology 4 sections *Neuroscience Seminar 40 sections *Drugs and Behavior 2 sections Mind 1 section *Application of Research Methods 51 sections *Seminar in Experimental Psychology 31 sections *Seminar in Neurodegeneration 3 sections *Neuroscience Laboratory 8 sections Neuropsychology 1 section *Seminar on Huntington’s Disease 3 sections Functional Neuroanatomy 1 section

*Developed this course

Advising

Psychology majors 218 Psychology minors 113 Neuroscience majors 114 Supervised 261 undergraduate honors or directed research projects Supervised over 150 Honors Students Supervised 103 undergraduate research grant winners Supervised 14 undergraduate Summer Scholar Fellows Supervised 9 winners of the Outstanding Undergraduate Research Poster Competition for the Michigan Chapter of the Society for Neuroscience Supervised Supervised 4 Student Travel Winners from the Faculty for Undergraduate Neuroscience Supervised 2 Undergraduate Research Fellowships from Sigma Xi, National Scientific Research Society Supervised 5 Ronald E. McNair Scholarship winners Supervised 3 Provost Award Winners for Outstanding Undergraduate Research

SERVICE

Departmental Service Served as Chair of Differential Equity Committee (May 1988-January 1989). Computer Committee (June 1988-November 1989). Research Methods Reorganization Committee (September 1988-May 1989). Space Allocation Committee (October 1989-April 1990). General Psychology M.A. Admissions Committee (March 1990-March 1992 and March 1995-Present). Library Committee (June 1991- March 1992). Organizer, CMU Homecoming Neuroscience Conference (October 1992). Member, General Psychology M.A. Program Review Committee (October 1992- March 1993). Chair, Committee to design a Ph.D. Program in Applied Experimental Psychology (September 1993-August 1998). Director, M.A. Program in General Psychology (August 1995-March 1998). Chair, Experimental Social Psychologist Search Committee (November 1995- April 1996). Member, Departmental Chairperson Search Committee (November 1995-April 1996). Member, Technology Committee (September 1996-December 1997) Member, Security Committee (September 1996-December 1997) Director, Graduate Programs in Experimental Psychology (March 1998-August 1999) Chair, Search Committee for Temporary Behavioral Neuroscientist (October 1998-June 1999) Member, Search Committee for Psychopharmacologist (August 2000-April 2001) Member, Experimental Program Admissions Committee (September 2000- March 2002) Chair, Search Committee for Behavioral Neuroscientist (August 20001-Jaunary 2002). Chairperson, Department of Psychology (August 2002-August 2005). Chair, Space Reallocation Committee (September 2002-March 2003). Chair, Behavioral Neuroscience Search Committee (August 2002-May 2003). Member, Graduate Admissions Committee (November 2007-April 2008).

College Service Alternative Workload Committee, College of Education, Health, and Human Services (January 1989-March 1989). Physical Therapy Advisory Committee, College of Education, Health, and Human Services (October 1993-January 1994). Physical Therapy Faculty Search Committee, College of Education, Health, and Human Services (February 1994-May 1996) Steering Committee, College of Humanities and Social and Behavioral Sciences (August 1997-July 1999) College Sabbatical Review Committee, College of Humanities and Social and Behavioral Sciences (October, 2002; October, 2004) Dean’s Advisory Council, College of Humanities and Social and Behavioral Sciences (August 2002-Present).

University Service

Institution Animal Care and Use Committee (October 1988-August 2005). Chair, (October 1990-April 1995), Secretary (October, 1996-October, 2000). Panelist, Centralis Scholarship Competition Academic Forum (October 6, 1990). Volunteer, Campus Community Campaign (April 1990). Athletic Committee (September 1990-May 1993). Secretary (September 1992 -May 1993). Mentor, Minority Student Mentor Program (August 1991-May 1992). Hazardous Waste Operations and Emergency Response Committee (August 1992-May 1995). Graduate Dean Search Committee (November 1993-May 1994). Panelist, CMU Grant Writing Workshop (September 9, 1994). Undergraduate Research Committee (January 1996-December 1999) Panelist, CMU Grant Writing Workshop (June 5, 1996) Faculty Mentor, New Student Enrichment Mentor Program (August 1997 -Present) Member, Academic Senate (August 1997-May 2000). Member, Graduate Credit Transfer Policy Committee (September 1997-February 1998) Member, Dissertation Fellowship Committee (September 1997-March 1999) Faculty Advisor, Central Neuroscience Society (August 1998-Present) Faculty Advisor, Nu Rho Psi, National Honor Society for Neuroscience (May 2014-Present). Director, Program in Neuroscience (January 1999-Present). Member, Steering Committee for Health Professions Building (March 1999 -June 2001) Faculty Mentor, Ronald E. McNair Scholars Program (January 2000-May 2005). Member, Academic Senate (August 2001-May 2006). Member, Faculty Migration (Champions) Committee for Technology Transfer in the Health Professions Building (January 2002-May 2005). Member, Advisory Committee, Ronald E. McNair Post-Baccalaureate Acheivement Program (January 2002-May 2003). Panel Facilitator, Animal Rights, Animal Welfare. Speak Up, Speak Out, The Current Event Series (October 9, 2002). Director, Program in Neuroscience (January 2003-Present). Director, Brain Research and Integrative Neuroscience Center (January 2003-Present). Physician Liaison Workgroup (January 2003-January 2006). Member, Health Professions Building Moving Committee (January 2003-January 2004). Member, Research Advisory Panel, Office of Research and Sponsored Programs (February 2003- December 2007). Member, Animal Care Coordinator Search Committee (October 2003-January 2004). Member, Health Professions Building Coordinating Committee (January 2004- Present). Member, Vice Provost Search Committee (May 2004-June 2004). Member, Vision Planning Steering Committee (June 2004-May 2005). Chairperson, Council of Chairs (July 2004-July 2005). Member, Budget Review Advisory Council (July 2004-December 2006). Member, Budget Restructuring Review Committee (September 2004-December 2006). Co-Chair, Research Subcommittee of the Institutional Strategic Planning Committee (September 2005-May 2006). Member, Institutional Strategic Planning Committee (September 2005-May 2006). Member, Academic Senate (August 2007-January 2009). Chair, Special Emphasis Committee of the Accreditation Self-Study Steering Committee (September 2004-December 2006). Member, Institutional Strategic Planning Committee (May 2005-December 2006). Member, Bridges Advisory Board (October 2005-October 2008). Member, Interdisciplinary Program Advisory Council (January 2007-December 2009). Medical School Vision Committee (January 2008-February 2008). Secretary and Member of Executive Board, Academic Senate (January 2008- January 2009). Member, CMU Medical School Dean Search Committee (September 2009-April 2010). Educational Development Committee, College of Medicine (September 2010-December 2012). Faculty Advisory Committee, College of Medicine (September 2010-December 2011). Curricular Committee, College of Medicine, (September 2010-December 2012). Associate Dean Search Committee, College of Medicine (September 2010-May 2011). Physical Therapy Advisory Committee, College of Health Professions (September 2010-Present). Neuroscience Course Development Director, College of Medicine, Central Michigan University (June 2011-January 2013). Interviewer, Medical Student Screening Committee, College of Medicine, Central Michigan University (October 20112-December 2012).

Service for Regional, National, and International Organizations

Judge, Regional Science Olympiad Tournament of the National Science Olympiad (April 8, 1989). Executive Committee, Faculty for Undergraduate Neuroscience (November 1991-November 2005). President, Faculty for Undergraduate Neuroscience (November 1994-November 1995). Program Faculty, Project Kaleidoscope (July 1995-2005). Volunteer, Cystic Fibrosis Foundation fund raiser (August 1995). Volunteer, Huntington's Disease Society of America, Mid-Michigan Chapter, Fun Day (October 1995). Councilor-at-large, Society for Neuroscience, Michigan Chapter (March 1994-May 1996). Secretary, Society for Neuroscience, Michigan Chapter (April 1996-April 1998) Scientific/Technical Advisor, Huntington’s Disease Society of America, Mid-Michigan Chapter (July 1996-Present). Coordinator, Brain Awareness Week activities, Mid-Michigan region (March 1997-Present). President-Elect, Michigan Chapter, Society for Neuroscience (1997-1998). Organizer, Annual Faculty for Undergraduate Neuroscience Student Poster Presentations (April 1998-November 1998). Volunteer, March of Dimes Campaign (January 1999). President, Michigan Chapter, Society for Neuroscience (May 1998-May 2000). Test Development for Graduate Record Examination, Educational Testing Services (November 1999-Present). Program Faculty, Project Kaleidoscope Workshop on Undergraduate Neuroscience Education: From the Enchanted Loom to the World Wide Web, Trinity College, Hartford, Connecticut, June 22-24, 2001. Board Member, Huntington’s Disease Society of America, Michigan Chapter (September 2002- August 2005). Member, Field Neurosciences Institute Research Committee (December, 2003-Present). Reviewer, The Neuron Connection, National Science Foundation (May 2004-December 2006). Member, Institutional Biologic Safety Committee, Field Neurosciences Institute (September, 2004-Present). Advisory Board Member, Support of Mentors and their Students in the Neurosciences, National Science Foundation (December 2004-Present). Board of Directors, Michigan Citizens for Stem Cell Research and Cures (January 2006-December 2011). External Reviewer, Society for Neuroscience, Neuroscience Core Concepts Initiative (September 2007-June 2008). Councilor, Society for Neuroscience, Michigan Chapter (August 2007-Present). Presenter, Survival Skills Workshop, Society for Neuroscience (October 2007-October 2011). Executive Director, Field Neurosciences Institute (September 2008-Present). Finance Committee, Field Neurosciences Institute (September 2008-Present). Fundraising Committee, Field Neurosciences Institute (September 2008-Present). Councilor, Michigan Chapter of the Society for Neuroscience (2000-Present). Member, Institutional Review Board, St. Mary’s of Michigan (September 2008-Present). Mentors in Mission Program, St. Mary’s of Michigan (October 2010-May 2011). Advisory Board Member, Nu Rho Psi, National Honorary Society for Neuroscience (October 2010-Present). Councilor, American Society for Neural Therapy and Repair (April 2010-April 2013). Committee on Animal Research and Ethics, American Psychological Association (March 2010- March 2014). Chair, Committee on Animal Research and Ethics, American Psychological Association (January 2012-January 2013). Faculty Mentor, Mid- and Late- Career Changes, Faculty Mentorship Program, Society for Neuroscience (October 2012-Present). Advisory Board, New Hope Assisted Living Facility (October 2012-Present). President, American Society for Neural Therapy and Repair (April 2014-Present).

Editorial Service

Editor, Special Projects, Restorative Neurology and Neuroscience (December 1997-December 2007). Editorial Board, Journal of Undergraduate Neuroscience Education (June 2002- Present). Associate Editor, Journal of Undergraduate Neuroscience Education, (June 2005- December 2006). Editor-in-Chief, Journal of Undergraduate Neuroscience Education, (January 2007-January 2012). Senior Editor, Journal of Undergraduate Neuroscience Education, (January 2012-Present). Associate Editor, Restorative Neurology and Neuroscience (January 2012-Present). Editorial Board, World Journal of Stem Cells (January 2012-Present). Editorial Board, Brain Injury (March 2014-Present). Editorial Board, Global Journal of Stem Cell Biology and Transplantation (June 2014-Present). Editorial Board, PLOS ONE (June 2014-Present)

Ad hoc Journal Reviewing

Behavior Research Methods, Instruments, and Computers Canadian Journal of Physiology and Pharmacology Psychobiology Behavioural Brain Research Restorative Neurology and Neuroscience Brain Research Bulletin Neuroscience Letters Physiology and Behavior Journal of Undergraduate Neuroscience Education Neuroscience and Biobehavioral Reviews Life Sciences Neurobiology of Learning and Memory Experimental and Clinical Psychopharmacology Pharmacology, Biochemistry, and Behavior Journal of Neuroscience Research Journal of Neurochemistry Neuroscience International Journal of Developmental Biology Journal of Neurochemistry Behavioral Genetics British Journal of Pharmacology Clinical and Experimental Pharmacology Brain Research Brain Injury Hippocampus Journal of Psychiatry and Neuroscience PLOS ONE Experimental Biology and Medicine International Journal of Molecular Science Immunology and Cell Biology Rejuvenation Research Anatomy Research International

Book Reviewing

Reviewer, Psychology: A Concise Introduction (Second Edition) by Terry F. Pettijohn, Dushkin Publishing Group, Inc. (October 1988-January 1989). Reviewer, Psychobiology, Brooks/Cole Publishing Company (July 1990). Reviewer, Principles of Behavioral Neuroscience by Jackson Beatty, Brown and Benchmark Publishers (January 1996). Reviewer, Biological Psychology by Steven Klein, Prentice Hall (October 1998). Reviewer, Biological Psychology by Steven Klein, Brooks/Cole Publishers (March-May 1999). Reviewer, Biological Psychology by James Kalat, Sixth Edition, Wadsworth Publishing Company (January-May 2000). Reviewer, Biological Psychology by James Kalat, Seventh Edition, Wadsworth Publishing Company (January-May 2001). Reviewer, Behavioral Genetics by Terence Bazzett, First Edition, Sinauer Associates (January- May 2007).

Grant Reviewing

Reviewer, grant proposal to the Ontario Mental Health Foundation (November 1990). Reviewer, Biology Panel of the National Science Foundation, Instrumentation and Laboratory Improvement Program (January 1993). Reviewer, grant proposal to Minority Biomedical Research Support Program, National Institute of Health (March 1994). Reviewer, Interdisciplinary Panel of the National Science Foundation, Instrumentation and Laboratory Improvement Program (January 1995). Reviewer, Interdisciplinary Panel of the National Science Foundation, Undergraduate Course and Curriculum Development Program and Faculty Enhancement Programs (July 1995). Reviewer, Psychology Panel of the National Science Foundation, Instrumentation and Laboratory Improvement Program (January 1996). Reviewer, Special Emphasis Panel, Center for Scientific Review, Small Business Innovation Research Program, National Institutes of Health (March 2000). Panelist, National Science Foundation, Assessment of Student Achievement in Undergraduate Education (ASA) Program, Arlington, Virginia (October 21-22, 2002). Consultant, Preclinical Meeting for Evaluating Compounds, National Institute of Drug Abuse, Bethesda, MD (April 29, 2003). Panelist, National Science Foundation, Assessment of Student Achievement in Reviewer, Undergraduate Education (ASA) Program, Arlington, Virginia (December 8-9, 2003). Panelist, Center for Scientific Review Special Emphasis Panel: Molecular, Cellular and Developmental Neurobiological Small Business Applications (ZRG1 MDCN-L 10, National Institutes of Health (March 2008). Reviewer, Neurological Foundation of New Zealand (May 2008). Panelist, Center for Scientific Review Special Emphasis Panel: Molecular, Cellular and Developmental Neurobiological Small Business Applications [2008/10 ZRG1 ETTN-D (13) B], National Institutes of Health (June 2008). Reviewer, Veterans Health Administration. Neurobiology Integrative Review Group (June 2009) Reviewer, James & Esther King Technology Transfer/Commercialization Partnership Program (July 2009-January 2010). Reviewer, Translational Research Grants, Parkinson’s Disease Society of Great Britain (January- May 2012). Reviewer, James & Esther King Technology Transfer/Commercialization Partnership Program (May 2012). Panelist, PROTECT proposals on early markers in Huntington’s disease, National Institutes of Neurological Disorders and Stroke (May 2012). Reviewer, James & Esther King Technology Transfer/Commercialization Partnership Program (February 2013). Reviewer, proposal to Health and Medical Research Fund, Government of The Hong Kong Special Administrative Region (March 2014). Panelist, American Association for the Advancement of Science review of proposal submitted to the Connecticut Bioscience Innovation Fund (May 2014).

SELECTED SCHOLARSHIPS, SABBATICALS, AND INTERNAL GRANTS

1988 Grant Development Award, Office of Research, Central Michigan University. Total award of $1500.

1989 Summer Research Fellowship, Central Michigan University. The use of d-amphetamine as a pharmacological treatment for motor and memory deficits following lesions of the frontal cortex. Total award of $2,400.

1991 Teaching Excellence Award, Central Michigan University. Total award of $2,500.

1991 Grant Development Award, Office of Research, Central Michigan University. Total award of $1,500.

1993 Faculty Research and Creative Endeavors Research Grant, Central Michigan University. GM1 ganglioside treatment in an animal model of Huntington's disease. Total award of $3,873.

1993 Research Excellence Fund, Central Michigan University. Development of a new animal model for Alzheimer's disease. Total award of $80,164.

1993 Sabbatical Leave, Central Michigan University

1997 Michigan Professor of the Year Award, Carnegie Foundation for the Advancement of Teaching and the Council for the Advancement and Support of Education. Total award of $1,000.

1998 College of Humanities and Social & Behavioral Sciences Summer Faculty Scholars award. Assessing a potential pharmacological treatment for Huntington’s disease. Total award of $2,000.

1998 Summer Teaching Fellowship award, Central Michigan University. Development of a new neuroscience major. Total award of $2400.

1999 Research Professorship, Central Michigan University. Assessment of GM1 ganglioside as a pharmacotherapy for neuropathological and behavioral deficits in the 3-nitropropionic acid model of Huntington’s disease.

2000 Sabbatical Leave, Central Michigan University.

2000 Faculty Research and Creative Endeavors Research Grant. Use of Co-enzyme Q10 and creatine as a combination treatment for neuroanatomical, cognitive, and motor deficits in the 3-nitropropionic acid model of Huntington’s Disease. Central Michigan University. Total award of $3,180.

2000 Scholarship Award, Huntington Disease Society of America, Michigan Chapter. Total award of $500.

2000 Research Excellence Funds grant. Center for Brain Research and Integrative Neuroscience. Central Michigan University. Total award of $169,987.

2001 President’s Research Investment Fund grant. Use of marrow stromal stem cells for treating neuroanatomical and behavioral deficits in a rodent model of Huntington’s disease. Total Award of $15,000.

2003 Faculty Research and Creative Endeavors Premier Display Grant. Creatine is more effective than coenzyme Q10 for reducing behavioral and neuroanatomical deficits in the 3-nitropropionic acid model of Huntington’s disease and Intravenous and intrastriatal injections of whole-bone-marrow stem cells attenuate cognitive and motor deficits in the R6/2 mouse model of Huntington’s disease. Total award of $1,000.

2005 Supplemental Equipment Award. Cryostat for Brain Research and Integrative Neuroscience Center. Central Michigan University. Total award of $50,000.

2007 Sabbatical Leave, Central Michigan University.

2012 Presidential Cohort Research Award. Enhancing biomedical research at CMU, Central Michigan University. Total award estimated to be over $500,000.

SELECTED EXTERNAL GRANTS AND CONTRACTS

1987-1992 Research grants (2): Testing GM1-ganglioside as treatment for behavioral deficits in brain damaged rats. Fidia Pharmaceutical Corporation, Abano Terme, Italy Total award (in-kind) of $68,000. Role: PI.

1989-1994 Research equipment grants (4): Surplus equipment for the Brain Research Laboratory at Central Michigan University. Dow Chemical and Dow Corning companies, Midland, Michigan. Total award (in-kind) of $100,000. Role: PI.

1990-1993 National Science Foundation Instrumentation and Laboratory Improvement Grant, with Drs. John Monahan (PI), Hajime Otani, Robert Sinclair, and Lynda King. Computer laboratory for undergraduate research and research design courses in psychology. Total award of $60,760. Role: Co-PI.

1991-1993 Research grant: Assessing the relationship of cholinergic markers and memory in the aged rodent model of Alzheimer’s disease. Upjohn Pharmaceutical Companty, Kalamazoo, Michigan. Total award (in-kind) of $25,000. Role: PI.

1992-1994 Fidia Neuroscience Research Laboratories. Ganglioside treatment in model of Huntington's disease. Total award (in kind) of about $18,000. Role: PI.

1993-1996 National Science Foundation Instrumentation and Laboratory Improvement. Concept-driven Laboratory Course in Behavioral Neuroscience. Total award of $51,954. Role: PI.

1995-1998 National Institute of Health Academic Research Enhancement Award. GM1 ganglioside treatment in an animal model of Huntington's disease. Total award of $87,132. Role: PI.

1997-1998 Research Supplement for Underrepresented Minorities, National Institute of Health. Total award of $4,170. Role: PI

1997-2000 Field Neurosciences Institute grant. Effects of low levels of lead on cognitive, motor, and neuroanatomical measures in young rats. Total award of $27,500. Role: PI.

1997-1999 Krenitsky Pharmaceuticals, Inc. grant. Effects of KP544 and KP565 on Physiological Health of Normal Rats. Total award of $3,000. Role PI.

1998-2000 Field Neurosciences Institute grant. Assessment of memory deficits in kindling models of epilepsy. Total award of $32,500. Role: PI.

1999-2001 Krenitsky Pharmaceuticals, Inc. grant. Assessment of physiological health in normal rats treated with nerve growth factor amplifier. Total award of $5,780. Role: PI.

2000-2003 Krenitsky Pharmaceuticals, Inc. grant. Use of nerve growth factor potentiators to counteract cognitive and motor deficits in a rodent model of neurodegeneration. Total award of $25,000. Role: PI.

2002-2003 Krenitsky Pharmaceuticals, Inc. grant. Effects of a novel monamine oxidase inhibitor on the physiological health of normal rats. Total award of $4,147. Role: PI.

2002-2007 Field Neurosciences Institute grant. Use of Adult Stem Cell as Potential Treatments for Neurodegenerative Diseases. Total Award of $250,000. Role PI.

2003-2006 Guilford Pharmaceuticals, Inc. contract. Effects of an immunophilin compound for treating cognitive dysfunction in aged rats. Total Award of $25,000. Role: PI.

2006-2009 Cerise Neutraceuticals, Inc. grant. Assessment of Cerise Total Body Rhythm on Learning and Memory Deficits in Rodent Models of Neurodeneration. Total award of $25,000. Role: PI.

2009-2014 Research contract: Testing the efficacy of adult stem cells for treating deficits in rodent models of Huntington’s disease, Alzheimer’s disease, stroke, and degenerative disc disease. Field Neurosciences Institute. Total award of $250,000. Role: PI

2011-2012 Research contract: Treatments of CXB 909 in a Mouse Model of Alzheimer’s Disease. CeNeRx Biopharma, Inc. Total award of $17,000. Role: PI.

2013-2015 Research contract: Assessing the efficacy of transplanting stem cells that are genetically altered to over-express brain derived neurotrophic factor in the YAC 128 mouse model of Huntington’s disease. Subcontract from University of California, Davis as part of their grant from the California Institute of Regenerative Medicine. Total award of $150,000. Role: PI.

2013-2016 Major Research Instrumentation Grant: Acquisition of a Fluorescence-Activated Cell Sorter for Multidisciplinary Research and Teaching at Central Michigan University. National Science Foundation. Total award: $419,000 . Role: Co-PI.

2014-2019 Research contract extension: Testing the efficacy of adult stem cells for treating deficits in rodent models of Huntington’s disease, Alzheimer’s disease, stroke, and degenerative disc disease. Field Neurosciences Institute. Total award of $250,000. Role: PI

SCHOLARLY ACTIVITY

Books

Dunbar, G.L. and Dunbar, D.S. Psychology and Human Behavior, Volumes I-V, First Edition. Kendall/Hunt Publishing Co., Dubuque, Iowa, 1982. Dunbar, G. L., Root, S., and Dunbar, D.S. Psychology and Human Behavior, Second Edition. Kendall/Hunt Publishing Co., Dubuque, Iowa, 1984. Lescaudron, L., Rossignol, J., and Dunbar, G.L. Stem Cells and Neurodegenerative Diseases. CRC Press, Taylor & Francis Group, Science Publishers, Enfield, New Hampshire, 2014.

Book Chapters and Monographs

Sabel, B.A., Dunbar, G.L., and Stein, D.G. (1984). Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. In Gorio, A. and Haber,B. (Eds.) Neurobiology of Gangliosides. Alan R. Liss, Inc., New York, pp. 429-443. Sabel, B.A., Dunbar, G.L., Fass, B., and Stein, D.G. (1985). Gangliosides, neuroplasticity, and behavioral recovery after brain damage. In Will, B.E., Schmitt, P., and Dalrymple-Alford, J.C. (Eds.) Brain Plasticity, Learning, and Memory. Plenum Publishing Corp., New York, pp. 481-493. Dunbar, G.L., *Butler, W., Fass, B., and Stein, D.G. (1987). Behavioral and neurochemical alterations by exogenous gangliosides in brain-damaged animals: problems and perspectives. In Tettamanti, G., Ledeen, R., Sandhoff, K., Nagai, Y., and Toffano, G. (Eds.) Gangliosides and Neuronal Plasticity. Liviana Press, Padova, pp. 365-380. Dunbar, G.L., *Hecht, S.A., *Merbaum, S.L., *DeAngelis, M.M., and Stein, D.G. (1987). Use of gangliosides and amphetamine to promote behavioral recovery following bilateral caudate nucleus lesions. In Masland, R.L., Portera-Sanchez, A., and Toffano, G. (Eds.) Neuroplasticity: A New Therapeutical Tool in the CNS Pathology. Liviana Press, Padova-Springer Verlag, pp. 117-124. Dunbar, G.L., and Stein, D.G. (1988). The use of ganglioside as a pharmacological treatment for behavioral deficits following CNS injury. In Sabel, B.A., and Stein, D.G. (Eds.) Pharmacological Approaches to Treatment of Brain and Spinal Cord Injury. Plenum Publishing Co., pp. 195-218. Williams, L.R., Tang, A.H., Rylett, R.J., Dunbar, G.L., Ingram, D.K., and Joseph, J.A. (1991). Correlation of cholinergic functional stimulation by exogenous NGF with aged rat behavior. In Becker, R. and Giacobini, E. (Eds.) Cholinergic Basis for Alzheimer's Therapy. Birkhauser, Boston, pp. 404- 411. Dunbar, G.L. (1997). Effects of lesion on spatial and nonspatial learning. In: Paul, C.A.,Beltz, B., Berger- Sweeney (Eds.) Discovering Neurons: The Experimental Basis of Neuroscience. Cold Spring Harbor Laboratory Press, Plainview, New York, pp. 283-301. Dunbar, G.L. (1998). A neuroscience program at a comprehensive state university: the Central Michigan University story. Occasional Paper on Neuroscience from the Project Kaleidoscope Workshop, Interdisciplinary Connections: Undergraduate Neuroscience Education, Project Kaleidoscope, Washington, D.C., pp. 5-10. Dunbar, G.L. (1998). Ganglioside Treatments in Animal Models of Stroke. In L.B. Goldstein (Ed.) Restorative Neurology: Advances in the Pharmacology for Recovery after Stroke, Futura Publishing Company, Inc., Armonk, NY, pp. 167-194. Dunbar G.L., #Shear D.A., #Dong J., and #Haik-Creguer K.L.. (1999). Cognitive and motor deficits produced by acute and chronic administration of 3-nitropropionic acid in rats. In P.R. Sanberg, H. Nishino, and C.V. Borlongan (Eds.), Mitochondrial Inhibitors and Neurodegenerative Disorders. Humana Press, Notowa, NJ, pp.73-92. Dunbar, G.L. (2004). Establishing an undergraduate neuroscience program at a medium-sized state university: chapter two of the Central Michigan University story. Project Kaleidoscope: http://www.pkal.org/template2.cfm?c_id=800. Dunbar, G.L., Oh-Lee, J.D., and Lescaudron, L. (2006). Use of bone marrow stem cells as therapy for behavioral deficits in rodent models of Huntington’s disease. In C.D. Sanberg and P.R. Sanberg (Eds.), Cell Therapy, Stem Cells, and Brain Repair, Humana Press, Inc., Notowa, N.J., pp. 117- 138. Rossignol, J., Lescaudron, L., and Dunbar, G.L. (2011). Nurturing roles of mesenchymal stem cells in reducing deficits in rodent models of Huntington’s disease. In Y. Xiao (Ed.): Mesenchymal Stem Cells, Nova Science Publishers, Hauppauge, NY., pp. 149-162. Lévêque, X.T., #Fink, K.D., Rossignol, J., Dunbar, G.L., and Lescaudron, L. (2012). The Use of Xenotransplantation in Neurodegenerative Diseases: A Way to Go? In S. Miyagawa (Ed.): Xenotransplantation, InTech, Rijeka, Croatia, pp 93-106. Sandstrom, M.I., #Steffes-Lovdahl, S., #Jayaprakash, N., #Wolfram-Aduan, A., and Dunbar, G.L. (2012). Early dysfunction of neural transmission and cognitive processing in Huntington’s disease. In N.E. Tunali (Ed.), Huntington’s Disease: Core Concepts and Current Advances, InTech, Rijeka, Croatia, pp. 201-232. #Fink, K.D., #Crane, A.T., Rossignol, J., Lescaudron, L., and Dunbar, G.L. The use of stem cells in treating Huntington's disease: state of research and prospects for future treatments. In Lescaudron, L., Rossignol, J., and Dunbar, G.L. (Eds.), Stem Cells and Neurodegenerative Diseases, CRC Press, Taylor & Francis Group,Science Publishers, Enfield, New Hampshire, pp 20-55.

Publications in Peer-Reviewed Journals

Dunbar, G.L. (1979). Effects of early feeding experience on chemical preference of the Northern water snake, Natrix s. sipedon. Journal of Herpetology, 13, 165-169. Sabel, B.A., Dunbar, G.L. and Stein, D.G. (1984). Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. Journal of Neuroscience Research, 12, 429-443. Sabel, B.A., Dunbar, G.L., *Butler, W.M. and Stein, D.G. (1985). GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigrostriatal pathway. Experimental Brain Research, 60, 27-37. Stein, D.G., Dunbar, G.L., *DeAngelis, M.M., *Hecht, S.A. and *Merbaum, S.L. (1987). Behavioral effects of exogenous gangliosides in adult rats with brain damage. Clinical Neuropharmacology 9: 336. Sabel, B.A., *Delmastro, R., Dunbar, G.L. and Stein, D.G. (1987). GM1 ganglioside educes anterograde degeneration in brain damaged rats. Neuroscience Letters, 77, 360-366. Dunbar, G.L., #Bishop, T.W., #Smith, G.A., #Janis, L.S., and *Nervig, L. (1992). d-Amphetamine treatments reduce motor deficits but not cognitive deficits after frontal lesions. International Journal of Psychology, 27: 416. Dunbar, G.L., Lescaudron, L.L., and Stein, D.G. (1993). Comparison of GM1 ganglioside, AGF2, and d- amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum. Behavioural Brain Research 54, 67-79. Dunbar, G.L., Rylett, R.J., Schmidt, B.M., Sinclair, R.S., and Williams, L.R. (1993). Hippocampal choline acetyltransferase activity correlates with spatial learning in aged rats. Brain Research, 604, 266- 272. #Janis, L.S., #Bishop, T.W., and Dunbar, G.L. (1994). Medial septal lesions in rats produce permanent deficits for strategy selection in a spatial memory task. Behavioral Neuroscience, 108, 892-898. *Shear, D.A., #Dong, J., *Haik-Creguer, K.L., Bazzett, T.J., Albin, R.L., and Dunbar, G.L. (1998). Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Experimental Neurology, 150: 305-311. #Haik-Creguer, K.L., Dunbar, G.L., Sabel, B.A., and Schroeder, U. (1998). Small drug sample fabrication of controlled release polymers using the microextrusion method. Journal of Neuroscience Methods 80: 37-40. #Shear DA, *Brandal SM, #Haik-Creguer KL, Dupont J, and Dunbar GL. (1998). Variable dosing regimen of systemic 3-nitropropionic acid administration produces spatial learning and motor deficits in both aged and young rats. European Journal of Neuroscience 10: 370. #Shear, D.A., #Dong, J., *Gundy, C.D., and #Haik-Creguer, K.L., and Dunbar, G.L. (1998). Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington’s disease. Progress in Neuro-Psychophamacology and Biological Psychiatry, 22(7): 1217-1240. #Haik, K.L., #Shear, D.A., Schroeder, U., Sabel, B.A., and Dunbar, G.L. (2000). Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington’s disease. Experimental Neurology 163: 430-439. #Shear, D.A., #Haik, K.L., and Dunbar, G.L. (2000). Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. NeuroReport 11: 1833-1837. Lescaudron, L. #Unni, D., and Dunbar, G.L. (2003). Autologous adult bone marrow stem cell transplantation in an animal model of Huntington’s disease: behavioral and morphological outcomes. International Journal of Neuroscience 113: 945-956. #Swan, L, Otani, H., Loubert, P.V., Sheffert, S.M., and Dunbar, G.L. (2004). Improving balance by performing a secondary cognitive task. British Journal of Psychology 95: 31-40. Dunbar, G.L., Lescaudron, L, #McClean, J.M., and Oh-Lee, J.D. (2004). Comparison of autologous and heterologous bone-marrow-derived stem cell transplants to counteract motor deficits in rodent models of Huntington’s disease and Parkinson’s disease. Abstract from the Eleventh Annual Conference of the American Society for Neural Transplantation and Repair. Experimental Neurology 187: 207. Dunbar, G.L. (2004). Privatization of Public Education: The Real Weapons of Mass Destruction. The Journal of Undergraduate Neuroscience Education 2(2): E2. #Gates, T.A., *Tran, M., Hulce, V.D., #Haik-Martines, K.L., and Dunbar, G.L. (2004). Chronic lead treatments produce aggressive behavior in a post-weaning rodent model of lead toxicity. The Journal of the Pennsylvania Osteopathic Medical Association 48(2): 12-16. #Wessell, R.H., *Ahmed, S.M., Menniti, F.S., Dunbar, G.L., Chase, T.N. and Oh-Lee, J.D. (2004). NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats. Neuropharmacology 47: 184-194. Krenitsky, T.A., Dillberger, J., Zotova, E., Arezzo, J.C., #Koprich, J.B., #Mortazavi , F., #Gates, T.A., and Dunbar, G.L. (2004). KP544, an Enhancer of Nerve Growth Factor: Pharmacokinetics, Safety and Efficacy in the Rat. Drug Development Research 62: 60-70. #Mortazavi, F., *Ericson, M., *Story, D. Hulce, V.D., and Dunbar, G.L. (2005) Spatial learning and emotional impairments in pentylenetetrazole-kindled rats. Epilepsy & Behavior 7: 629-638. #Shear, D.A., Tate, C.C., Tate, M.C., Archer, D.R., Hulce, V.D., LaPlaca, M.C., Dunbar, G.L., Stein, D.G. (2006). Neural stem cell transplantation for traumatic brain injury. Journal of Neurotrauma 23(6): 1032. Dunbar, G.L., Sandstrom, M.I., #Rossignol, J., Lescaudron, L. (2006). Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington’s disease: Use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behavioral and Cognitive Neuroscience Reviews 5: 63-79. Dunbar, G.L., #McClean, J.M., #Myers, R.A., #Dey, N.D., *Boersen, A.J., *York, L.R., and Lu, M. (2006). Comparison of the therapeutic efficacy of the substituted pyrimidine, KP544, for counteracting cognitive and motor deficits in four rodent models of Huntington’s disease. Experimental Neurology 198: 558-597. Dunbar, G.L. (2007). JUNE as the voice for undergraduate neuroscience education. Journal of Undergraduate Neuroscience Education 5(1): E6. #Dey, N.D., *Bombard, M.C., #Myers, R.A., *Boersen, A.J., *Roland, B.P., Sandstrom, M.I., Lescaudron, L., Hamilton, G., Williams, L., and Dunbar, G.L. (2007). The novel neruoimmunophillin, GPI 1485, attenuates age-related cognitive deficits in rats. Cell Transplantation 16(3): 319-320. #Shear, D.A., Tate, C.C., Tate, M.C., Archer, D.R., Dunbar, G.L, LaPlaca, M.C., and Stein, D.G. (2007). Effects of timing, location, and environment on neural stem cell transplant survival, migration, and differentiation following experimental traumatic brain injury. Journal of Neurotrauma 24(7) 1229- 1288. Dunbar, G.L. (2007). Mentorship: The bond that brings us together. Journal of Undergraduate Neuroscience Education 6(1): E1. #Andrus, A.K., Marable, B.R., Dunbar, G.L., Reilly, M.P., and Maurissen, J.P.J. (2007). Effects of intensity and type of prepulse stimulus on prepulse inhibition in scopolamine treated rats. Pharmacology, Biochemistry, and Behavior 87: 481-488. #Dey, N.D., *Boersen, A.J., #Myers, R.A..,*York, L.R., *Bombard, M.C., Lu, M., Sandstrom, M.I., Hulce, V.D., Lescaudron, L., and Dunbar, G.L. (2007). The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington’s disease. Restorative Neurology and Neuroscience 25: 485-492. Dunbar, G.L. (2008). New challenges and changes for JUNE. Journal of Undergraduate Neuroscience Education 6(2): E7-E7. #Martines, K.H., #Shear, D. A., *Hargrove, C., *Patton, J., *Mazei-Robison, M., Sandstrom, M.I., and Dunbar, G.L. (2008). 7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease. Experimental and Clinical Psychopharmacology 16: 178-189.

*Bombard, M.C., #Dey, N.D., *Roland, B.P., Lu, M., #Matchynski, J., #Lowrance, S., Rossignol, J., Sandstrom, M.I., Lescaudron, L., and Dunbar, G.L. (2008). Intrastriatal transplantation of bone marrow stem cells that are genetically engineered to overexpress brain derived neurotrophic factor reduces behavioral deficits in the yeast artificial chromosome mouse model of Huntington’s disease. Cell Transplantation 17: 462. Dunbar, G.L. (2008). Lessons in hope. Journal of Undergraduate Neuroscience Education 7(1): E1-E1. Rossignol, J., #Boyer, C., Thinard, R., Remy, S., Dugast, A.S., Dubayle, F., #Dey, N.D., Delecrin, J.,Heymann, D.,Vanhove, B., Anegon, I., Naveilhan, P., Dunbar, G.L., and L. Lescaudron. (2009). Absence of immune response of the rat striatum after allo/xeno transplantation of mesenchymal stem cells. Journal of Cellular and Molecular Medicine 13: 1-12. Dunbar, G.L. (2009). A special time for JUNE. Journal of Undergraduate Neuroscience Education 7(2): E2-E2. Dunbar, G.L. (2009). Donald G. Stein: Pioneer in the areas of neuroplasticity and recovery of function. Journal of Undergraduate Neuroscience Education 7(2): E3-E5. Rossignol, J., #Boyer, C., Leveque, X., Dunbar, G., and Lescaudron, L. (2009). Mesenchymal stem cell transplants reduce behavioral deficits in the 3-nitropropionic rat model of Huntington’s disease. Cell Transplantation 18: 27. Dunbar, G.L., Lom, B. Grisham, W., and Ramirez, J.J. (2009). The Journal of Undergraduate Neuroscience Education: History, challenges, and future directions. Journal of Undergraduate Neuroscience Education 8(1): A78-A81. #Dey, N.D., *Bombard, M.C., *Roland, B.P., *Davidson, S., Lu,M., Rossignol, J., Sandstrom, M.I., Skeel, R., Lescaudron, L., and Dunbar, G.L. (2010). Genetically-engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behavioural Brain Research 214: 193-200. Dunbar, G.L. (2010). Bryan Kolb: Pioneer in neuropsychology and role model for teaching, mentoring, and involving undergraduates in neuroscience research. Journal of Undergraduate Neuroscience Education 8(2): E3-E4. Rossignol, J., #Fink, K.D., *Davis, K.K., *Cheng, S., #Lowrance, S.A., #Matchynski, J.J., Lescaudron, L., and Dunbar, G.L. (2010). Mesenchymal stem cell transplants reduce behavioral deficits in the R6/2 rodent model of Huntington’s Disease. Cell Transplantation 19(3): 359. Dunbar, G.L. (2010). We are JUNE. Journal of Undergraduate Neuroscience Education 9(1): E1-E1. Rossignol, J., #Boyer, C., #Lévêque, X., Thinard, R., Blanchard, F., Dunbar, G.L., Lescaudron, L. (2011). Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington’s disease: Morphological and behavioral investigations. Behavioural Brain Research 217: 369-378. #Shear, D.A., Tate, C.C., Tate, M.C., Archer, D.R., LaPlaca, M.C., Stein, D.G., Dunbar, G.L. (2011). Stem cell survival and functional outcome after traumatic brain injury is dependent on transplantation timing and location. Restorative Neurology and Neuroscience 29: 215-225. Dunbar, G.L. (2011). Friends, FUN, and the future. Journal of Undergraduate Neuroscience Education 9(2): E4-E4. Rossignol, J., Fink, K.D., Hissock, N.L., Bavar, A.M., Crane, A.T., Lescaudron, L., and Dunbar, G.L. (2011). Effect of the sources an dpasswage numbers on efficacy of mesenchymal stem cell transplants in the R6/2 mouse model of Huntington’s disease. Cell Transplantation 20: 581. Olson, S.D., #Pollock, K., Kambal, A., Cary, W., Mitchell, G.M., Tempkin, J., Stewart, H., McGee, J., Bauer, G., Kim, H.S., Tempkin, T., Wheelock, V., Annett, G., Dunbar, G.L., Nolta, J.A. (2011). Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Molecular Neurobiology 45(1): 87-98. Dunbar, G.L. (2011). Julio Ramirez honored for outstanding mentorship by President Obama. Journal of Undergraduate Neuroscience Education 9(2): E8-E9. #Lowrance, S., #Matchynski, J.J., Rossignol, J., *Dekorver, N., Sandstrom, M.I., and Dunbar, G.L. (2012). CXB-909 attenuates cognitive deficits in the mu-P-75 saporin mouse model of Alzheimer’s disease. Neuroscience & Medicine 3 (1): 65-68. #Wekchko, R.M., Lévêque, X.T., and Dunbar, G.L. (2012). Genetic rat models of Parkinson’s disease. Parkinson's Disease 2012: 1-6. #Fink, K., Rossignol, J., #Crane, A., *Davis, K., *Bavar, A., *Dekorver, N., #Lowrance, S., Reilly, M., Sandstrom, M.I., von Hörsten, S., Lescaudron, L., and Dunbar, G.L. (2012). Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington’s disease. Behavioral Neuroscience 126: 479-487. Wiertelak, E.P. and Dunbar, G.L. (2012). Shared innovations in education: Writing and reviewing for the undergraduate neuroscience community. Journal of Undergraduate Neuroscience Education 11(1): A112-A113. #Fink, K.D., #Crane, A.T., Rossignol, J., Leveque, X., *Starski, P., *Heranes, R., Lu, M., Nguyen, T. H., Lescaudron, L., and Dunbar, G.L. (2012). Adenovirus-generated induced pluripotent stem cells survive and differentiate into mature neuronal phenotypes following transplantation into a healthy rat striatum. Cell Transplantation 21: 777-778. Lescaudron, L., Boyer, C., #Bonnamain, V., #Fink, K.D., Lévêque, X., Rossignol, J., Nerrière-Daguin,V., Malouet, A.C., Lelan, F., Dey, N.D., Michel-Monigadon, D., Lu, M., Neveu, I., von Hörsten, S., Naveilhan, P., and Dunbar, G.L. (2012). Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases. Methods in Molecular Biology 879: 147-164. #Matchynski, J.J., #Lowrance, S.A.,*Pappas, C., Rossignol, J., *Puckett, N., Sandstrom, M.I., and Dunbar, G.L. (2013). A combinatorial treatment of tart cherry extract and essential fatty acids reduces cognitive impairments and inflammation in the mu-p75 saporin-induced mouse model of Alzheimer’s disease. Journal of Medicinal Food 16: 288-295. Leveque, X., #Welchko, R., #Shall, G., #Fink, K.D., Lu, M., Rossignol, J., and Dunbar, G.L. (2013). Use of dopaminergic neurons derived from rat induced-pluripotent stem cells. Cell Transplantation 22: 908. #Fink, K.D., Rossignol, J., #Crane, A.T., *Davis, K.K., *Bombard, M.C., *Bavar, A. M., *Clerc, S., #Lowrance, S.A., *Song, C., Lescaudron, L., and Dunbar, G.L. (2013). Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis. Stem Cell Research & Therapy 4: 130-142. #Crane, A.T., #Fink, K.D., Rossignol, J., *Wyse, R., *Dues, D.J., *Starski, P.A., and Dunbar, G.L. (2013). Mesenchymal stem cells: source and passage number alter behavioral outcomes and life span in the R6/2 mouse model of Huntington’s disease. Cell Transplantation 22: 899. #Fink, K.D., Rossignol, J., #Crane, A.T., #Hulse, T.D., Leveque, X., #Wyse, R., *Dues, D.J., *Huffman, L.D., *Moore, A.C., #Story, D.T., *Dejonge, R., Lu, M., Lescaudron, L., and Dunbar, G.L. (2013). Transplantation of adenovirus-generated induced pluriopotent stem cells into Huntington’s disease striatum: Analysis of survival, differentiation, and recovery of function. Cell Transplantation 22: 902. Rossignol, J., #Fink, K.D., #Crane, A.T., *Davis, K., *Clerc, S., #Matchynski, J., #Lowrance, S., *Bombard, M., *Derkover, N., Lescaudron, L., and Dunbar, G.L. (2014). Mesenchymal and adult neural stem cell transplantations in a transgenic rat model of Huntington’s disease. Stem Cells 32: 500-509. #Wyse, R.D., Dunbar, G.L., and Rossignol, J. (2014). Use of genetically modified stem cells to treat neurodegenerative diseases. International Journal of Molecular Science 15: 1719-1745. Rossignol, J., #Crane, A.T., #Fink, K.D., and Dunbar, G.L. (2014) Will undifferentiated induced pluripotent stem cells ever have clinical utility? Journal of Stem Cell Research & Therapy 4: 4-7. #Crane, A.T., Rossignol, J., and Dunbar, G.L. (2014) Use of genetically altered stem cells for the treatment of Huntington's disease. Brain Sciences, 4, 202-219. #Fink, K.D., #Crane, T.A., Rossignol, J., Lévêque, X., *Dues, D.J., *Huffman, L.D., *Moore, A.C., #Story, D.T., *Dejonge, R.E., #Antcliff, A., #Hulse, T.D., Lu, M., Lescaudron, L., Dunbar, G.L. (2014) Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington’s disease. Stem Cells and Translational Medicine, 3(5):620-31. #Crane, A.T., #Fink, K.D., Grace, K.A., Grace, A.R., Antcliff, A.K., Neale, A.C., Wyse, R., Rossignol, J., and Dunbar G.L. (2014). Transplantation of adenovirus generated induced pluripotent stem cells in the 51 CAG transgenic rat model of Huntington’s disease. Cell Transplantation 23: 767-768. #Lowrance, S.A., #Fink, K.D., #Crane, A., #Matyas, J., #Dey, N.D., *Thibo, T., *Reinke, T., *Kippe, J., *Hoffman, C., Sandstrom, M., Rossignol, J., and Dunbar, G.L. (2014). Bone marrow derived mesenchymal stem cells attenuate cognitive deficits in an enothelin-1 rat model of stroke. Restorative Neurology and Neuroscience (in press). #Fink, K.D., Rossignol, J., Lu, M., Leveque, X., #Hulse, T.D., #Crane, A.T., Nerriere-Daguin, V., #Wyse, R.D., *Starski, P.A., *Schloop, M.T., *Dues, D.J., *Witte, S. J., *Song, C., Vallier, L. , Nguyen, T. H., Naveilhan, P. Andgon, I., Lescaudron, L., and Dunbar, G. L. (2014). Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum. Cell Transplantation (in press).

* indicates undergraduate student co-author and # indicates graduate student co-author

Conference Presentations, Abstracts, and Proceedings at National/International Conferences

Sabel, B.A., Dunbar, G.L., *Butler, W.M. and Stein, D.G. (1984). The treatment of brain injury with GM1-ganglioside: behavioral recovery and neuronal reorganization after unilateral transection of the nigrostriatal pathway. EBBS-SFECA Workshop on Brain Plasticity, Learning, and Memory, Strasbourg, France, September 1. Dunbar, G.L., Sabel, B.A., Firl, A.C. and Stein, D.G. (1984). GM1 gangliosides stimulate neuronal reorganization and behavioral recovery after nigrostriatal hemitransections: an HRP study. Society for Neuroscience Abstracts, 10, 1051. Stein, D.G., Dunbar, G.L., Fass, B., *Butler, W.M. and Sabel, B.A. (1985). The role of gangliosides in promoting functional recovery from acute brain injuries. Satellite Meeting of the XIII World Congress of Neurology: Acute Brain Ischemia, Sienna, Italy, September 11-14. Stein, D.G., Sabel, B.A., Dunbar, G.L. and *Butler, W.M. (1985). Gangliosides enhance behavioral recovery and neuronal repair in brain damaged rats. International Society for Neurochemistry Satellite Meeting: Neuronal Plasticity and Gangliosides. Fidia Research Series, Frontiers in Neuroscience, No. 8, 32-33. Stein, D.G., Dunbar, G.L., *DeAngelis, M.M., *Hecht, S.A. and *Merbaum, S.L. (1986). Behavioral effects of chronic ganglioside administration in adult rats with brain injury. Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injuries: Second International Clark/Luxembourg Neuroscience Conference, Walferdange, Luxembourg, July 7-11. Dunbar, G.L. and Stein, D.G. (1986). GM1 ganglioside and d-amphetamine treatments reduce spatial learning deficits caused by bilateral damage to the caudate nucleus. Fidia Research Series: Frontiers in Neuroscience, Abstract Book No. 10, 18. Dunbar, G.L., *DeAngelis, M.M., *Hecht, S.A., *Merbaum, S.L. and Stein, D.G. (1986). Systemic injections of GM1 ganglioside and d-amphetamine reduce spatial learning deficits caused by bilateral damage to the caudate nucleus. Society for Neuroscience Abstracts, 12, 1283. Dunbar, G.L., *Sapozhnikov, P., and Stein, D.G. (1987). GM1 gangliosides are ineffective in reducing amphetamine-induced rotational asymmetry, but protect rats from aphagia and adipsia following complete nigrostriatal hemitransections. Society for Neuroscience Abstracts, 13, 1608. Dunbar, G.L., Lescaudron, L.L., #Bitran, B.S., *Hecht, S.A., and Stein, D.G. (1988). Treatment of ganglioside and amphetamine fail to reduce spatial learning deficits in a water-maze task following bilateral lesions of the caudate nucleus. Society for Neuroscience Abstracts, 14, 1246. Dunbar, G.L., #Smith, G.A., #Look, S.K., and *Whalen, R.J. (1989). d-Amphetamine attenuates learning and motor deficits following cortical injury in rats. Society for Neuroscience Abstracts, 15, 132. Dunbar, G.L., Rylett, R.J., and Williams, L.R. (1990). Hippocampal choline acetyltransferase activity correlates with spatial learning deficits in aged rats. Society for Neuroscience Abstracts, 16, 840. *Kotasek, R.S., Janis, L.S., and Dunbar, G.L. (1991). Rats prefer a pattern strategy over a distal-cue strategy in a radial maze task. Midwest Animal Behavior Conference, Midland, Michigan, April 12-14. Dunbar, G.L., #Smith, G.A., #Janis, L.S., *Snyder, B.J., and *Mead, L.A. (1991). Treatments of d- amphetamine reduce age-related memory deficits in rats. Society for Neuroscience Abstracts, 17: 1141. #Bishop, T.W., *Curtis, C.L., *Briscoe, R.J., and Dunbar, G.L. (1992). Medial septal lesions disrupt spatial working memory without impairing nonspatial working memory in rats. Midwestern Psychological Association 64th Annual Meeting, Chicago, Illinois, April 30. #Janis, L.S., *Weaver, C.L., and Dunbar, G.L. (1992). Lesions of the nucleus basalis temporarily disrupt spatial memory task performance. American Psychological Society 4th Annual Meeting, San Diego, California, June 20-22. #Janis, L.S., *Weaver, C.W., *Kocot, M.A., *Mosher, T.L., and Dunbar, G.L. (1992). Spatial memory performance of rats on a working memory task does not require the presence of visual distal cues. Society for Neuroscience Abstracts, 18, 1426. #Curtis, C.L., #Ross, G.J., *Hyde, E.A., *Szymanski, R.E., *Hull, J.S., and Dunbar, G.L. (1992). Intrastriatal injections of quinolinic acid cause spatial learning deficits in rats. Society for Neuroscience Abstracts, 18, 1602. Dunbar, G.L., #Janis, L.S., and *Weaver, C.L. (1993). Differential impairment of spatial learning in two animal models of Alzheimer's disease. Society for Neuroscience Abstracts, 19, 1045. #Weaver, C.L.,#Copley, L.M., #Couturier, R.Z., and Dunbar, G.L. (1994). Chronic intracerebroventricular ethanol administration impairs nonspatial memory in rats. Society for Neuroscience Abstracts, 20, 1610. Dunbar, G.L., #Weaver, C.L., and Kent, M.A. (1994). Concept-driven laboratory course in behavioral neuroscience. Society for Neuroscience Abstracts, 20, 204. Dunbar, G.L., #Copley, L.M., #Couturier, R.Z., and #Eyal, G. (1995). Estrogen treatments attenuate AMPA-induced memory deficits in male rats. Alzheimer's Disease: The Promise of New Therapeutics. Danvers, MA, June 8-9. Dunbar, G.L., #North, M.C., *Haik, K.L., and #Dong, J. (1995). Acute injections of quinolinic acid cause dose-dependent spatial memory deficits in rats. Society for Neuroscience Abstracts, 21: 1941. Paul, C.A., Dunbar, G.L., and Wilson, J. (1995). Models for neuroscience education at undergraduate institutions. Society for Neuroscience Abstracts, 21: 249. #Dong, J., *Shear, D.A., *Gundy, C.D., #Haik-Creguer, K., and Dunbar, G.L. (1996). Behavioral and histological comparisons of two animal models of Huntington’s disease. Society for Neuroscience Abstracts, 22: 227. #Haik-Creguer, K.L., #Shear, D.A., #Dong, J., Sabel, B.A., and Dunbar, G.L. (1997). Slow release of quinolinic acid from polymers implanted in the striatum produces spatial learning deficits in rats. Society for Neuroscience Abstracts 23: 1908. #Shear, D.A., #Dong, J., #Haik-Creguer, K.L., Bazzett, T.J., Albin, R.L., and Dunbar, G.L. (1997). Chronic intrastriatal administration of quinolinic acid produces cognitive deficits in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 23: 1908. *Mazei, M. and Dunbar, G.L. (1997). GM1 ganglioside attenuates spatial learning deficits induced by intrastriatal injections of quinolinic acid in a rodent model of Huntington’s disease. Faculty for Undergraduate Neuroscience Meeting, New Orleans, Louisiana, October 28. *Sorenson, J. and Dunbar, G.L. (1997). 7-Nitroindazole attenuates cognitive deficits induced by 6- hydroxydopamine in an animal model of Parkinson’s disease. Faculty for Undergraduate Neuroscience Meeting, New Orleans, Louisiana, October 28. Ramirez, J.J., Aanonsen, L., Dunbar, G.L., Hill, W., Paul, C.A., and Smith, D.A. (1998). Undergraduate education in the neurosciences: four blueprints. Occasional Paper on Neuroscience from the Project Kaleidoscope Workshop, Interdisciplinary Connections: Undergraduate Neuroscience Education. Project Kaleidoscope, Washington, D.C., pp. 27-31. #Shear DA, #Haik-Creguer K.L., *Brandal, S.M., Dupont, J., and Dunbar, G.L. (1998). Systemic administration of 3-nitropropionic acid in progressively increasing concentrations produces spatial learning impairment and motor abnormalities relevant to Huntington's disease. Society for Neuroscience Abstracts, 24(1): 970. *Mazei M.S., #Haik-Creguer, K.L., #Shear, D.A., *Sorenson, J.J., and Dunbar, G.L. (1998). GM1 ganglioside reduces quinolinic acid-induced behavioral deficits. Society for Neuroscience Abstracts, 24(1): 970. #Haik-Creguer, K.L., #Shear, D.A., Gorzinski, S., Dupont, J., Benson, E.W., Hulce, V.D., and Dunbar, G.L. (1998). Subchronic low level lead exposure in postweaning rats produces spatial learning deficits as measured in the radial arm water maze. Society for Neuroscience Abstracts, 24(1): 237. #Shear, D.A., *Brandal, S.M., #Haik-Creguer, K.L., Dupont, J., and Dunbar, G.L. (1998). Variable dosing regimen of systemic 3-nitropropionic acid administration produces spatial learning and motor deficits in both aged and young rats. European Journal of Neuroscience, 10: 370. #Shear, D.A., #Haik-Creguer, K.L., and Dunbar, G.L. (1999). Creatine attenuates spatial learning impairment and motor abnormalities in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 25: 590. #Haik-Creguer, K.L., #Shear, D.A., Gorzinski, S., Benson, E.W., Hulce, V.D., and Dunbar, G.L. (1999). Spatial learning deficits are produced in postweaning rats following chronic low level lead exposure. Society for Neuroscience Abstracts 25: 1831. #Haik, K.L., #Shear, D.A., *Mazei,M., and Dunbar, G.L. (2000). 7-Nitroindazole attenuates spatial learning deficits induced by bilateral intrastriatal injections of 6-hydroxydopamine in an animal model of Parkinson’s disease. Society for Neuroscience Abstracts 26: 747. #Shear, D.A., #Haik, K.L., *Kersting, T.L., and Dunbar, G.L. (2000). Synergistic effects of creatine and coenzyme Q10 in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 26: 1300. #Mortazavi, F., *Ericson, M., *Story, D., Hulce, V.D., and Dunbar, G.L. (2000). Pentylenetetrazole causes spatial learning deficits and abnormal emotional reactivity in an animal model of epilepsy. Society for Neuroscience Abstracts 26: 1055. Makhay, M. M., Dunbar, G.L., #Koprich, J.B., #Mortazavi, F., and *O’Donnell, J.M. (2001). Effects of rolipram in rats with memory deficits induced by quinolinic acid in a radial-arm water maze task. Society for Neuroscience Abstracts 27: 319.9. #Koprich, J.B., #Mortazavi, F., #Gates, T.A., *Hadley, S., and Dunbar, G.L. (2001). Novel substituted pyrimidine, KP546, reduces quinolate-induced learning deficits in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 27: 968.5. #Gates, T.A., *Church, J., *Hancock, C., DeCorte,R., and Dunbar, G.L. (2001). Novel neurotrophin enhancing compound, KP66, attenuates behavioral deficits in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 27: 968.9. Lescaudron, L., #Unni, D., and Dunbar, G.L. (2002). Behavioral and morphological outcomes of autologous bone marrow derived stem cell transplantation in an animal model of Huntington’s disease. Eighth International Conference on Neural Transplantation and Repair, Keystone, Colorado, June 13-16, 2002. *Barrett, L.M., *Ahmed, S.M., Oh-Lee, J.D., and Dunbar, G.L. (2002). Neuropahtological and behavioral consequences of unilateral intrastriatal injections of quinolinic acid in a rodent model of Huntington’s disease. HD2002 Hereditary Disease Foundation Conference, Boston, Massachusetts, August 8-11, 2002. Dunbar, G.L., Lescaudron, L., and Oh-Lee, J.D. (2002). Behavioral consequences of heterologous bone marrow derived stem cell transplants in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 28: 195.3. Oh-Lee, J.D., Chase, T.N., and Dunbar, G.L. (2002). Protein kinase C (PKC), but not FYN, transgenic mice are protected against haloperidol-induced motor dysfunction. Society for Neuroscience Abstracts 28: 249.3. Dunbar, G.L., #McClean, J.M., #McQuaide, J., Krenitsky, T. A., Dilberger, J., Scharver, J.D., and Hulce, V.D. (2003). Use of a substituted pyrimidine, KP 544, to counteract cognitive and motor deficits in two rodent models of Huntington’s disease. Society for Neuroscience Abstracts 29: 409.19. Fyfe, J.A., Beauchamp, L.M., Dunbar, G.L., and Krenitsky, T.A. (2003). Amplification of nerve growth factor effects by KP544. Society for Neuroscience Abstracts 29: 97.2. #Dey, N.D., #McClean, J.M., #Myers, R.A.,*Boersen, A.J., *York, L.R., and Dunbar, G.L. (2004). The novel substituted pyrimidine KP544 attenuates 3-nitropropionic-acid-induced deficits in a rat model of Huntington’s disease. Society for Neuroscience Abstracts 30: 223.5. #McClean, J.M., #Myers, R.A., #Dey, N.D., *York, L.R., *Boersen, A.J., Novitski, C.E., and Dunbar, G.L. (2004). The substituted pyrimidine KP544 protects against cognitive deficits in the R6/2 transgenic mouse model of Huntington’s disease. Society for Neuroscience Abstracts 30: 223.6. Dunbar, G.L., #McClean, J.M., #McQuaide, J.A., *Hall, S., Oh-Lee, J.D. (2004). Use of substituted pyrimidine to counteract cognitive and motor deficits in a rodent model of Huntington’s disease. Society for Neuroscience Abstracts 30: 223.7. #Wessel, R.H., *Basse, J.L., *Shandelmayer, T.L., Dunbar, G.L., and Oh, J.D. (2004). Effects of 6-HODA nigrostriatal dopaminergic deneervation on emotional, spatial, and operant learning in rats. Society for Neuroscience Abstracts 30: 563.10. Oh, J.D., Lescaudron, L., #McClean, J.M., and Dunbar, G.L. (2004). Comparison of autologous and heterologous bone-marrow-derived stem cell transplants to counteract motor deficits in rodent models of Huntington’s and Parkinson’s disease. Society for Neuroscience Abstracts 30: 790.1. #Dey, N.D., *Boersen, A.J., #Myers, R.A., *York, L.R., Lu, M. Shear, D.A., Hulce., V.D.,and Dunbar, G.L. (2005). Attenuation of motor but not cognitive deficits after post-symptomatic treatment with KP544 in the R6/2 transgenic mouse model of Huntington’s disease. Society for Neuroscience Abstracts 31: 1009. #Myers, R.A., *Boersen, A.J., *York, L.R., #Dey, N.D., #Shear, D.A., Hulce, V.D., Lu, M., and Dunbar, G.L. (2005).. Presymptomatic dosing of the substituted pyrimidine, KP544, reduces behavioral deficits in the R6/2 mouse model of Huntington’s disease. Society for Neuroscience Abstracts 31: 1009.6. Dunbar, G.L., #Myers, R., *Boersen, A., *York, L., Lu, M., and Sandstrom, M.I. (2006). Treatments with the substituted pyrimidine, KP544, reduces cognitive and motor deficits in the R6/2 mouse model of Huntington’s disease. HD 2006: Changes, Advances, and Good News (CAG)n, Royal Sonesta Hotel Boston, Cambridge, Massachusetts, August 11, 2006. #Shear, D.A., #Martines, K.H., Hulce, V.D., and Dunbar, G.L. (2006). Creatine is more ffective than coenzyme Q10 on reducing behavioral and neuroanatomical deficits in the 3- nitropropionic acid model of Huntington’s disease. Society for Neuroscience Abstracts 32: 472.14. #Dey, N.D., *Bombard, M.C., *Roland, B.P., *Burkhardt, A.L., *Neihoff, A.A., *Sawyer, N.L.,*Heist, K.A., Lu, M., and Dunbar, G.L. (2006). Intravenous and intrastriatal injections of whole-bone- marrow stem cells attenuate cognitive and motor deficits in the R6/2 mouse model of Huntington’s disease. Society for Neuroscience Abstracts 32: 758.10. *Bombard, M.C., #Dey, N.D., *Roland, B.P., Lu, M., Sandstrom, M.I., #Shear, D.A., Lescaudron, L., and Dunbar, G.L.(2007). Adult, bone-marrow-derived stem cells that are genetically engineered to over-express brain derived neurotrophic factor and nerve growth factor reduce behavioral deficits in the yeast artificial chromosome transgenic mouse model of Huntington’s disease . Society for Neuroscience Abstracts 33: 51.13. #Martines, K.H., #Shear, D.A., *Hargrove, C.A., *Patton, J., *Mazei-Robison, M., and Dunbar, G.L. (2007). 7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson’s disease. Society for Neuroscience Abstracts 33: 254.14. #Rossignol, J., #Boyer, C., #Leveque, X., Dunbar, G.L., and Lescaudron, L. (2007). Mesenchymal stem cell transplantation in the striatum of a rat model of Huntington's disease: a new restorative cellular therapy. Society for Neuroscience Abstracts 33: 765.5. #Dey, N.D., *Bombard, M.C., #Myers, R.A., *Boersen, A.J., *York, L.R., *Roland, B.P., Sandstrom, M.I., Lescaudron, L., Hamilton, G., Williams, L., and Dunbar, G.L. (2007). The neuroimmunophilin, GPI-1485, ameliorates age-induced spatial learning deficits in the Morris water maze task. Society for Neuroscience Abstracts 33: 937.21. #Shear, D.A., Tate, C.C., Tate, M.C., Archer, D.R., Dunbar, G.L., LaPlaca, M.C., and Stein, D.G. (2007). Neural stem cell mediated functional recovery following traumatic brain injury is not dependent on migration or phenotypic differentiation of transplanted cells. Society for Neuroscience Abstracts 33: 494.1. *Bombard, M.C., #Dey, N.D., #Lowrance, S.L., #Matchinksy, J. J., *Roland, B.P., Lu, M., Rossignol, J., Sandstrom, M.I., Lescaudron, L., and Dunbar, G.L. (2008). Use of Cerise Total Body Rhythm to reduce behavioral deficits in the R6/2 transgenic mouse model of Huntington’s disease. Hereditary Disease Foundation Bi-Annual Meeting, Boston, Massachusetts, July 9. Dunbar, G.L., *Bombard, M.C., #Dey, N.D., *Roland, B.P., Lu, M., #Matchynski, J.J, #Lowrance, S.A., Rossignol, J., Sandstrom, M.I., and Lescaurdron, L. (2008). Genetically engineered stem cells reduce behavioral deficits in the yeast artificial chromosome mouse model of Huntington’s disease. Hereditary Disease Foundation Bi-Annual Meeting, Boston, Massachusetts, July 9. Rossignol, J., #Boyer, C., #Matchynski, J.J., #Lowrance, S.A., #Dey, N.D., Lu, M., Raber, K., Von Horsten, S., Dunbar, G.L., and Lescaudron, L. (2008). Adult mesenchymal stem cell and neural stem cell transplantations in the striatum of a transgenic rat model of Huntington's disease. Society for Neuroscience Abstracts, 211.6. Lom, B.M., Dunbar, G.L., and Grisham, W. (2008). The Journal of Undergraduate Neuroscience Education (JUNE): an open journal of pedagogical innovations. Society for Neuroscience Abstracts, 224.11. *Bombard, M.C., #Dey, N.D., #Lowrance, S.A., #Matchynski, J.J., *Roland, B.P., Lu, M., Rossignol, J., Sandstrom, M.I., Lescaudron, L., and Dunbar, G.L., (2008). Use of a dietary supplement consisting of anti-oxidants and omega fatty acids 3, 6, and 9 to reduce behavioral deficits in the R6/2 transgenic mouse model of Huntington’s disease. Society for Neuroscience Abstracts, 744.6. Dunbar, G.L., Lom, B.A., Grisham, W. (2009). Journal of Undergraduate Neuroscience Education (JUNE): Free resources for undergraduate faculty. Society for Neuroscience Abstracts 21.24. Rossignol, J., *Davis, K.K., *Clerc, S.C., #Lowarance, S.A., #Matchynski, J.J.,*Bombard, M.C., #Fink, K.D., Raber, K., Von Horsten, S., Lescaudron L., and Dunbar, G.L. (2009). Synergistic effects of combining adult neural stem cells with mesenchymal stem cells as a transplant therapy in the transgenic rat model of Huntington’s disease. Society for Neuroscience Abstracts 240.20. #Matchynski, J.J., #Lowrance, S.A., Rossignol, J., *Puckett, N., *Derkorver, N., *Radwan, J.,*Trainor, K., Sandstrom, M., and Dunbar, G.L. (2009). Intracerebroventricular injections of mu-P-75 saporin can produce memory deficits without impairing motor deficits in a mouse model of Alzheimer’s disease. Society for Neuroscience Abstracts 528.1. Rossignol, J., #Boyer, C., #Fink, K.D., *Davis, K. K., *Clerc, S.C., #Lowrance, S.A., #Matchynski, J.J., Von Horsten, S., Lecaudron, L., and Dunbar, G.L. (2009). Striatal stem cell transplantations in a transgenic rat model of Huntington’s disease. Fourth Meeting of the World Congress on Huntington’s Disease, Vancouver, Canada, September 12-15. Rossignol, J., #Boyer, C., #Matchynski, J.J., #Lowrance, S.A., Lu, M., Raber, K., Von Horsten, S., Dunbar, G.L., and Lescaudron, L. (2009). Adult neural stem cells and mesenchymal stem cells as a transplant therapy for transgenic rat model of Huntington’s disease. Ninth Annual Meeting of the French Society for Neuroscience, Bordeaux, France, May 26-29. Rossignol, J, #Fink, K.D, *Davis, K.K, *Cheng, S, #Lowrance, S.A, #Matchynski, J.J, Lescaudron L, and Dunbar G.L. (2010). Mesenchymal stem cell transplants reduce behavioral deficits in the R6/2 mouse model of Huntington's disease. Seventeenth Annual Conference of the American Society for Neural Therapeutics and Repair, Clearwater, Florida, April 30. #Fink, K.D., Rossignol, J., *Davis, K.K., Reilly, M.P., Von Horsten, S., Lescaudron, L., and Dunbar, G.L. (2010). Early cognitive dysfunction in a transgenic rat model of Huntington’s disease. Forum of European Neurosciences Abstracts, 5: 046.11. Rossignol, J., #Fink, K.D., *Davis, K.K., *Schafer, A.Y., #Lowrance, S.A., #Matchynski, J.J., Lescaudron, L., and Dunbar, G.L. (2010). Striatal transplantation of mesenchmal stem cells reduce behavioral deficits in the r6/2 mouse model of Huntington’s disease. Forum of European Neurosciences Abstracts 5: 046.24. Rossignol, J, #Fink, K.D, *Davis, K.K, *Cheng, S, #Lowrance, S.A, #Matchynski, J.J, Lu, M.,Lescaudron L, and Dunbar G.L. (2010). Mesenchymal stem cells reduce behavioral deficits in rodent models of Huntington’s disease. Hereditary Disease Foundation Abstracts p.156: No. 140. #Matchynski, J. J., #Lowrance, S. L., Rossignol, J., *DeKorver, N. *Puckett, N. D., *Pappas, C., *Trainor, K., *Radwan, J., #Dey, N., and Dunbar, G. L. (2010). The effects of a combination of antioxidants and essential fatty acids as treatment for Alzheimer's disease in the mu-p75 saporin- injected model. Society for Neuroscience Abstracts: 856.15. Rossignol, J., #Fink K.D, *Davis K.K, *Dekorver N.W, #Matchynski J.J, #Lowrance S.A, Lescaudron L, and Dunbar G.L (2010). Mesenchymal stem cell transplantations in the R6/2 mouse model of Huntington's disease. Society for Neuroscience Abstracts: 862.7. #Fink K.D, J.Rossignol., *Davis K.K, *Bavar A.M, #Lowrance S.A, #Matchynski J.J, Reilly M.P, Sandstrom M, Von Horsten S, Lescaudron L, Dunbar G.L. (2010). Cognitive deficits emerge prior to neuronal loss or anatomical changes in the HD 51 CAG rat model of Huntington’s disease. Society for Neuroscience Abstracts: 861.24. #Lowrance, S.A., #Matchynski, J.J., Rossignol, J., *DeKorver, N., #Fink, K.D.,. *Salibi, P., and Dunbar, G.L. (2010). KRX-0501 Reduces Cognitive Deficits in a Saporin Mouse Model of Alzheimer’s Disease. Society for Neuroscience Abstracts: 856.8. Dunbar, G.L., Lom, B.A., and Grisham, W. (2010). JUNE—Journal of Undergraduate Neuroscience Education: An open access resource for neuroscience educators. Society for Neuroscience Abstracts: 24.9. Rossignol, J., #Fink, K.D, *Davis, K.K., #Lowrance, S.A, #Matchynski, J.J,, Lescaudron, L, and Dunbar, G.L (2010). Striatal transplantation of Mesenchymal stem cell reduce behavioral deficits in the R6/2 mouse model of Huntington's disease. Forum of European Neurosciences Abstracts: 046.24. #Fink, K.D., Rossignol, J., *Davis, K.K., Reilly, M.P., Von Hörsten, S., Lescaudron, L., Dunbar, G.L. (2010). Early Cognitive Dysfunction in a Transgenic Rat Model of Huntington’s disease using an Operant Conditioning Paradigm. Forum of European Neurosciences Abstracts: 046.24. Rossignol, J., #Fink, K..D., *Davis, K.K., *Cheng, S., #Lowrance, S.A., #Matchynski J.J., Lu, M., Lescaudron, L., Dunbar, G.L. (2010). Mesenchymal stem cell transplants reduce behavioral deficits in the rodent models of Huntington's disease. Biannual meeting of the Hereditary Disease Foundation, Boston, Massachusetts, August 5. Rossignol J., #Fink K.D.,*Wyse, R., #Crane, A.C., #Lowrance, S.A., #Matyas, J.J., Reilly, M.P., Von Hörsten, S., Lescaudron, L., Dunbar, G.L. (2011). Early Cognitive Dysfunction in a Transgenic Rat Model of Huntington’s Disease Using a Spatial Operant Reversal Task (SORT). Poster, Huntington Disease World Congress, Melbourne, Australia, September 12. #Lowrance, S.A., #Matyas, J., Rossignol. J., #Crane, A., #Fink, K.D., #Dey, N., #Matchynski, J.J., *McGrath, C., *Tharp, M., and Dunbar, G.L. (2011) Using the spontaneous operant reversal task (SORT) to identify behavioral deficits in an endothelin-1 model of stroke in rats. Society for Neuroscience Abstracts: 674.03. #Matchynski, J.J., Rossignol, J., #Fink, K. D., #Crane, A., *Twite, A., *Pappas, C.A., *Song, C., #Lowrance, S.A., #Matyas, J.J., and Dunbar, G.L. (2011). Mesenchymal stem cells as treatment for Alzheimer’s disease in the 5xFAD mouse model. Society for Neuroscience Abstracts: 532.09. Rossignol, J., #Crane, A.T., #Fink, K.D., *Tharp, M.A., *Bavar, A.M., *Moser, M.N., *Schloop, M.T., *Uchel, T. A., Sweeting, R.M., and Dunbar, G.L. (2011). Mesenchymal stem cell transplants in the R6/2 mouse model of Huntington’s disease: Passage and source variations. Society for Neuroscience Abstracts: 557.15. #Fink, K.D., Leveque, X., #Crane, A.T., Rossignol, J., Lu, M., Nguyen, T.H., Lecaudron, L., and Dunbar, G.L. (2011). Survival and differentiation of transplanted adenovirus-generated induced pluripotent stem cells. Society for Neuroscience Abstracts: 650.11. *Wyse, R., #Crane, A., #Fink, K., Rossignol, J., and Dunbar, G.L. (2011). Differentiation capacity of mesenchymal stem cells into neuronal-like cells. Society for Neuroscience Abstracts: 756.23. #Crane, A., #Fink, K.D., Rossignol, J., #Lowrance, S.A., #Matyas, J.J., Sandstrom, M.I., Moskal, J.R., and Dunbar, G.L. (2011). Treating behavioral deficits in the 51 CAG rat model of Huntington’s disease with a NMDA receptor partial agonist, GLYX-13. Society for Neuroscience Abstracts: 358.17. Wiertelak, E.P., Grisham, W., and Dunbar, G.L. (2011). Undergraduate Neuroscience Education: An open access resource for neuroscience educators. Society for Neuroscience Abstracts: 25.11. #Wolfram-Aduan, A., *Knirk, J., *Wickwire, J., Rossignol, J., #Crane, A., *Knoll, A., #Lowrance, S.A., #Matyas, J.J., *Koepke, B., *Gilardone, J., *Mandziara, M.C., #Jayaprakash, N., Dunbar, G.L., Moskal, J., and Sandstrom, M.I. (2011). Globus pallidus neurochemical responses to the partial NMDA agonist GLYX-13 among HD 51 CAG Huntington’s disease model rats. Society for Neuroscience Abstracts: 248.07. #Fink, K.D., #Crane, A.T., Rossignol, J., #Wyse, R.D., *Huffman, L., *Moore, A., Lu, M., Lescaudron, L., and Dunbar, G.L. (2012). Transplantation of adenovirus-generated induced pluripotent stem cells protect against motor deficits in the 3-nitropropionic acid rat model of Huntington’s disease. Hereditary Disease Foundation Abstracts: 24. Leveque, X., #Welchko, R., #Fink, K., Rossignol, J., Lescaudron, L., and Dunbar, G.L. (2012). Differentiation of induced-pluripotent stem cells into dopaminergic neurons for transplantation in a rodent model of Parkinson’s disease. Midwest Conference on Stem Cell Biology and Therapy, Rochester Hills, Michigan, October 4. Wiertelak, E., Grisham, W.E., and Dunbar, G. (2012). Journal of Undergraduate Neuroscience Education (June): An open access journal for undergraduate neuroscience pedagogy. Society for Neuroscience Abstracts: 25.06. #Matyas, J.J., #Matchynski, J.J., *Schloop, M., Leveque, X., Sandstrom, M., and Dunbar, G.L. (2012). Neuroscience Outreach Programs in mid-Michigan: Brain awareness week and brain bee events. Society for Neuroscience Abstracts: 28.22. Panicker, D., Bennett, A.J., Carroll, M.E., Dunbar, G., Higa, J., McGwin, J., Scott-Johnson, P., and Swain, R. (2012). A history of the American Psychological Association’s committee on animal research and ethics (care) Society for Neuroscience Abstracts: 30.01. Dunbar, G. L., Panicker, S., Scott-Johnson, P., Higa, J. J., Swain, R. A., Bennett, A. J., and Carroll, M. E. (2012). Promoting the importance of non-human animal research for health: Initiatives by the American Psychological Association (APA) Committee on Animal Research and Ethics Society for Neuroscience Abstracts: 30.02. Bennett, A. J., Carroll, M. E., Dunbar, G., Higa, J., McGwin, J., Panicker, S., Scott-Johnson, P., and Swain, R. (2012). Reaching out: Public education and engagement about animal research Society for Neuroscience Abstracts: 30.03. Carroll, M. E., Dunbar, G. L., Panicker, S., Scott-Johnson, P., Higa, J. J., Swain, R. A., and Bennett, A. J. (2012). Ways universities can support animal research and protect investigators and their animals from extremist attacks Society for Neuroscience Abstracts: 30.19. #Wyse, R. D., *Culver, R. L., #Crane, A. T., #Fink, K. D., Rossignol, J., and Dunbar, G. L.(2012). In vitro evaluation of EGF- and BFGF-treated mesenchymal stem cells that closely resemble neuronal stem cells. Society for Neuroscience Abstracts: 33.10. #Lowrance, S. A., #Fink, K., #Crane, A., Rossignol, J., *Thibo, T., *Kippe, J., *Reinke, T. J., *Harrington, A., *Hoffman, C., *Lada, N., *Yelick, K., #Matchynski, J. J., #Matyas, J.J., and Dunbar, G.L. (2012). Low passage bone marrow derived mesenchymal stem cells reduce cognitive errors in the spontaneous operant reversal task (SORT) in an endothelin-1 model of stroke in rats. Society for Neuroscience Abstracts: 59.04. #Crane, A., #Fink, K. D., #Wyse, P.A., *Starski, J., Rossignol, J., and Dunbar, G.L. (2012). Transplantation of mesenchymal stem cells increases survivability of R6/2 mouse model of Huntington’s Disease. Society for Neuroscience Abstracts: 63.13. #Fink, K.D., #Crane, A.T., Rossignol, J., Leveque, X., #Wyse, D., *Hoffman, L.D., #Moore, A. C., Lu, M., Nguyen, T., Anegon, I., Ludovic, L., Lescaudron, L., and Dunbar, G. L. (2012). Transplantation of adenovirus-generated induced pluripotent stem cells into both healthy and Huntington’s disease rat striatum: Analysis of survival, differentiation, and recovery of function. Society for Neuroscience Abstracts: 119.10. Leveque, X., #Welchko, R., #Fink, K., Rossignol, J., Lescaudron, L., and Dunbar, G.L. (2012). Use of dopaminergic neurons derived from rat induced-pluripotent stem cells in a rat model of Parkinson’s disease. Society for Neuroscience Abstracts: 546.16. #Matchynski, J. J., Rossignol, J., *Pappas, C., #Fink, K., #Crane, A., #Lowrance, S. A., #Matyas, J. J., and Dunbar (2012). Mesenchymal stem cells as treatment for cognitive and neuropathological deficits in the 5xFAD mouse model of Alzheimer’s disease. Society for Neuroscience Abstracts: 852.11. Dunbar, G.L., Rossignol, J., #Fink, K.D., #Crane, A.T., #Wyse, R.D., and Lu, M. (2013). Use of mesenchymal stem cells for treating cognitive and motor deficits in rodent models of Huntington’s disease. Fourth Annual Eckerd College Science Symposium, Eckerd College, St. Petersburg, Florida, February 9. *Reinke, T. J., #Matchynski, J. J., *Abdelazim, S., #Lowrance, S. A., Rossignol, J., and Dunbar, G. L. (2012). Antioxidants from tart cherries and essential fatty acids as treatment for cognitive deficits in the 5xFAD mouse model of Alzheimer’s disease. Society for Neuroscience Abstracts: 852.16. *Dunkerson, J., *Moritz, K., *Pionk, T., #Fink, K.D., Dunbar, G.L., and Smith. J.S. (2012). The impact of enriched environment and transplantation of induced pluripotent stem cells on recovery from controlled cortical contusion injury. Faculty for Neuroscience Education Research Poster Session, New Orleans, Louisiana, October 15. Dunbar, G.L., Rossignol, J., #Fink, K.D., #Crane, A.T., #Wyse, R.D., and Lu, M. (2013). Use of mesenchymal stem cells for treating cognitive and motor deficits in rodent models of Huntington’s disease. Fourth Annual Eckerd College Science Symposium, Eckerd College, St. Petersburg, Florida, February 9.

*Mudd, D., #Matyas, J.J., Dunbar, G.L., and Smith, J.S. (2013). The effects of mesenchymal stem cells on disc structure in a rat caudal model of intervertebral disc degeneration. Faculty for Neuroscience Education Research Poster Session, New Orleans, Louisiana, October 15. Wiertelak, E.P., Johnson, B., Dunbar, G.L., and Grisham, W.E. (2013). Free online resource for neuroscience educators: Journal of Undergraduate Neuroscience. Society for Neuroscience Abstracts 22.10. *Moore, A.C., #Crane, A.T., Lu, M., Rossignol, J., and Dunbar, G.L. (2013). Genetic modification and characterization of mesenchymal stem cells to overexpress human and mouse brain derived neurotrophic factor. Society for Neuroscience Abstracts 47.08. *Starski,P.A., *Ernst, C., *Schloop, M.T., *Cady,A., *Dues, D.J., #Wyse, R.D., #Crane, A.T., #Fink, K.D., Rossignol, J., and Dunbar, G.L. (2013). Adipose derived stem cell transplants reduce behavioral deficits in the R6/2 mouse model of Huntington’s disease. Society for Neuroscience Abstracts 47.13. *Hall, T., #Lowrance, S. *Reinke, T., #Matchynski, J., #Matyas, J.J., #Fink, K.D., *Laberdee, A., *Thibo, T., *Hoffman, C., *Yelick, K., #Hulse, T., #Story, D., *Dues, D., Rossignol, J., and Dunbar G.L. (2013). The sthort-term and long-term effects of CXB-909 treatment on cognition and neuropathology in the 5xFD mouse model of Alzheimer’s disease. Society for Neuroscience Abstracts 134.28. #Shall, G., Leveque,X., #Welchko, R., #Fink, K.D., Lu, M., Rossignol, J., and Dunbar, G.L. (2013). Use of dopaminergic neurons derived from rat induced pluripotent stem cells in a rat model of Parkinson’s disease. Society for Neuroscience Abstracts 138.11. #Welchko, R., #Hulse, T., #Shall, G., *Parker, S., *Huo, W., *Decker, S., *Menosky, M., *Dues, D., Leveque, L., Lu, M., Rossignol, J., and Dunbar, G.L. (2013). Utilization of a novel adenovirus for differentiation of mesenchymal stem cells into dopaminergic neurons. Society for Neuroscience Abstracts 138.16. *Huo, W., #Welchko, R., #Hulse, T., *Parker, S., *Dues, D., *Dai, D., Leveque, X., Rossignol, J., Lu, M., and Dunbar, G.L. (2013). Up-regulation of transcription factors and target genes involved in the differentiation process of mesnchymal stem cells into dopaminergic neuron-like cells. Society for Neuroscience Abstracts 138.17. #Fink, K.D., #Crane, A.T., Rossignol, J., Leveque, X., *Dues, D.J., *Huffman, L.D., *Moore, A.C., #Story, D.T., *Antcliff, A., Lu, M., Lescaudron, L., and Dunbar, G. L. (2013). Transplantation of adenovirus-generated induced pluripotent stem cells reduces neuropathological and functional deficits in a toxic-lesion rodent model of Huntington’s disease. Society for Neuroscience Abstracts 306.10. #Crane, A.T., #Fink, K.D., *Grace, K.A., *Antcliff, A., #Wyse, R., Lu, M., Lescaudron, L., Rossignol, J., and Dunbar, G.L. (2013). Transplantation of adenovirus generated induced pluripotent stem cells in the 51 CAG transgenic rat model of Huntington’s disease. Society for Neuroscience Abstracts 414.12. *Dues, D., *Huffman, L., #Fink, K.D., #Hulse, T., Rossignol, J., and Dunbar, G.L. (2013). Bone marrow- derived mesenchymal stem cells in the treatment of glioma. Society for Neuroscience Abstracts 446.11. *Duffy, J.D., *Neale, A., #Fink, K.D., #Crane, A.T., Rossignol, J., and Dunbar, G.L. (2013). Comparison of bone marrow-derived mesenchymal stem cells with different labels. Society for Neuroscience Abstracts 489.02. #Matchynski, J., Brown, S.L, #Matyas, J.J., Hagerman, B., Dunbar, G.L., and Jenrow, K. (2013). Prounounced memory deficits as early as 28 days pot 12 gray whole brain irradiation. Society for Neuroscience Abstracts 631.07. *Culver, R., #Welchko, R., #Hulse,T., #Shall, G., *Parker, S., *Huo, W. *Dues, D., Leveque, X., Lu, M., Rossignol, J., and Dunbar, G.L. (2013). Adenoviral transfection of the rat F98 glioblastoma cell line for development of a neuronal differentiation model. Society for Neuroscience Abstracts 796.11. #Welchko, R., #Hulse, T., #Shall, G., *Parker, S., *Huo, W., *Watters, J., *Decker, S., *Menosky, M., *Dues, D., *Dai D., Leveque X., Rossignol J., Lu M., Dunbar G. (2013). Forced differentiation of mesenchymal stem cells into dopaminergic neurons with a polycistronic expression adenovirus. Grand Challenges in Parkinson’s Disease Symposium, Grand Rapids, Michigan, September 19. #Shall, G., Leveque, X., Welchko, R., Fink, K.D., Lu, M., Rossignol J., and Dunbar, G.L. (2013). Use of dopaminergicneurons derived from rat induced-pluripotent stem cells in a rat model of Parkinson’s disease. Grand Challenges in Parkinson’s Disease Symposium, Grand Rapids, Michigan, September 19. *Baker, K. J, Leveque, X., Welchko, R., Shall, G., Rossignol, J., and Dunbar, G. L. (2013). Non-drug- induced motor behavior screening substitute for drug-induced rotation in 6-OHDA hemiparkinsonian rat models. 2013. Grand Challenges in Parkinson’s Disease Symposium, Grand Rapids, Michigan, September 19.

* indicates undergraduate student co-author and # indicates graduate student co-author

SELECTED INVITED TALKS, COLLOQUIA, AND SEMINARS

Dunbar, G.L. Reduction of lesion-induced learning deficits by GM1 Ganglioside. Colloquium for Department of Psychology, University of South Alabama, Mobile, Alabama, March 10, 1987. Dunbar, G.L. Pharmacological treatment of behavioral deficits following brain injury. Colloquium for Psychology Department, Fordham University, Bronx, New York, April 8, 1987. Dunbar, G.L. Use of gangliosides as treatment for behavioral deficits following brain damage. Neuroscience Seminar Series, University of Connecticut, Storrs, Connecticut, May 1, 1987. Dunbar, G.L. Use of d-amphetamine as a treatment for behavioral deficits following brain damage. Neuroscience Seminar, Rutgers University, Newark, New Jersey, June 13, 1989. Dunbar, G.L. Use of GM1-ganglioside to reduce behavioral deficits following brain damage. Neuroscience Seminar Series, Michigan State University, E. Lansing, Michigan, February 2, 1989. Dunbar, G.L. The use of GM1 ganglioside as a pharmacological treatment for behavioral deficits after brain damage. Biopsychology Colloquium, University of Michigan, Ann Arbor, Michigan, December 12, 1989. Dunbar, G.L., Smith, G.A., Janis, L.S., Snyder, B.J., and Mead, L.A. Treatments of d-amphetamine reduce age-related memory deficits in rats. Faculty Creativity Day, Central Michigan University, Mt. Pleasant, Michigan, March 25, 1992. Dunbar, G.L. Establishing an undergraduate neuroscience program in a mid-sized university. Annual Meeting of the Association for Neuroscience Departments and Programs, Washington, D.C., April 19, 1993. Dunbar, G.L. Current issues in undergraduate neuroscience education. Annual Meeting of the Association for Neuroscience Departments and Programs, Washington, D.C., April 25, 1995. Dunbar, G.L. An undergraduate neuroscience program at a state university. Project Kaleidoscope Workshop on Interdisciplinary Connections: Undergraduate Neuroscience Education. Davidson College, Davidson, NC, July 28-30, 1995. Dunbar, G.L. Huntington’s disease: Possible causes, models, and potential treatments. Keynote address at the Second Annual Michigan Convention of the Huntington’s Disease Society of America. Lansing, Michigan, April 27, 1996. Dunbar, G.L. Animal models of Huntington’s disease: implications for subcortical cognition. Eighty-ninth Annual Meeting of the Southern Society for Philosophy and Psychology, Atlanta, Georgia, March 28, 1997. Dunbar, G.L. Research with animal models of Huntington’s disease. Address at the Third Annual Michigan Convention of the Huntington’s Disease Society of America. Lansing, Michigan, April 19, 1997. Dunbar, G.L. The search for an effective treatment for Huntington’s disease. Meeting of the Mid- Michigan Chapter of the Huntington’s Disease Society of America. Grand Rapids, Michigan, May 21, 1997. Dunbar, G.L. Use of neurotoxins in animal models of Huntington’s disease. Talk for the Midland Chapter of Sigma Xi. Midland, Michigan, May 13, 1998. Dunbar, G.L. Let your heart lead the way. Keynote Address at Cadillac Senior High School Commencement Ceremony. Cadillac, Michigan, May 31, 1998. Dunbar, G.L. Effects of lesion on spatial and nonspatial learning. Workshop presented at Project Kaleidoscope Interdisciplinary Connections: Blueprints for Reform in Undergraduate Neuroscience, Oberlin College, Oberlin, Ohio, June 12-14, 1998. Dunbar, G.L. Morrie’s lessons for life. Keynote Address at Central Michigan University Convocation. August 31, 1998. Dunbar, G.L. Possible strategies for the treatment of Huntington’s disease. Keynote Address at the General Meeting of the Mid-Michigan Chapter of the Huntington’s Disease Society of America. Lansing, Michigan, September 19, 1998. Dunbar, G.L. Huntington’s disease: Animal models and potential treatments. Talk given at Davidson College. Davidson, North Carolina, March 11, 1999. Dunbar, G.L. Psychology in the twenty-first century. Keynote Address for the 13th Annual Michigan Undergraduate Psychology Research Conference, Albion College, Albion, Michigan, April 8, 2000. Dunbar, G.L. Potential pharmacological treatments for Huntington’s disease. Thirty- second Annual Best Paper Lecture, Midland Chapter of Sigma Xi, Midland, Michigan, April 18, 2000. Dunbar, G.L. Low-cost behavioral assays: cognitive and motor assessments in rodents. Project Kaleidoscope Workshop on Undergraduate Education: From the Enchanted Loom to the World Wide Web. Trinity College, Hartford, Connecticut, June 22-24, 2001. Dunbar, G.L. Potential treatments for cognitive and motor deficits in rodent models of Huntington’s disease. Talk given to Michigan State University Neuroscience Seminar Series. Michigan State University, East Lansing, Michigan, February 22, 2001. Dunbar, G.L. Research for treatment of Huntington’s disease. Keynote address, General Meeting of the Michigan Chapter of the Huntington’s Disease Society of America. Lansing, Michigan, September 22, 2001. Dunbar, G.L. Testing potential therapies for cognitive and motor deficits in rodent models of Huntington’s disease. Talk given to University of Michigan Biopsychology Seminar Series, University of Michigan, Ann Arbor, Michigan, October 15, 2002.. Dunbar, G.L. Testing Potential Treatments in Rodent Models of Huntington’s Disease. Keynote address at the annual business meeting of the Michigan Chapter of the Huntington’s Disease Society of America. Lansing, Michigan, September 27, 2003. Dunbar, G.L. Ethical Questions Concerning the Use of Stem Cell and Gene Therapies. Presentation at “The Ethical Frontiers of Biomedicine” symposium at Montcalm Community College, Sidney, Michigan, October 14, 2003. Dunbar, G.L. New Initiatives in Teaching Undergraduate Neuroscience. Invited presentation to Association of Neuroscience Departments and Programs, Washington, D.C., May 2, 2004. Dunbar, G.L. Hunting Treatments for Huntington’s Disease: A Researcher’s Personal Journey. Keynote address at the semi-annual meeting of the Michigan Chapter for Huntington’s Disease Society of America, Lansing, Michigan, September 18, 2004. Dunbar, G.L. Research as a Critical Component of Education: Student-Centered Studies using Stem Cell Transplants. Keynote Address, Central Missouri State University Scholars Symposium, Warrensburg, Missouri, April 3, 2006. Dunbar, G.L. Experimental Therapies for Cognitive and Motor Deficits in Rodent Models of Huntington's Disease. Neuroscience Seminar, University of North Dakota Medical School, Grand Forks, North Dakota, October 9, 2006. Dunbar, G.L. Experimental Therapies for Huntington’s Disease. Talk given at University of Nantes Neuroscience Seminar, Nantes, France, April 10, 2007. Dunbar, G.L. and Baum, M. Stem Cell Research for Rehabilitation. Talk given at the Michigan Rehabilitation Conference, Grand Rapids, Michigan, October 25, 2007. Dunbar, G.L. and Ramirez, J.J. Graduate School: Applying and Succeeding. Talk given at the Survival Workshop, Society for Neuroscience, San Diego, California, November 3, 2007. Caucus, Central Michigan University, Mt. Pleasant, Michigan, April 2, 2008. Dunbar, G.L. Use of Dietary Supplements, Neurotrophic Factors, and Stem Cells as Treatments for Huntington’s Disease. Talk given to Flint Support Group of the Michigan Chapter of Huntington’s Disease Society of America, Flint, Michigan, June 2, 2008. Dunbar, G.L. (2008). JUNE and you. Workshop presentation at Project Kaleidoscope/Faculty for Undergraduate Workshop at McAlester College, St. Paul, Minnesota, July 18-20. Dunbar, G.L. and Rossignol, J. (2008). Use of adult stem cells as therapy for Huntington’s Disease. Talk given to Huntington’s Disease Society of America, Michigan Chapter Meeting, Warren, Michigan, September 20. Dunbar, G.L. (2008). Stem cells and treatments for Huntington’s disease. Talk given to the Michigan Association of Rehabilitation Nurses, Detroit, Michigan, September 23. Dunbar, G.L. (2008). How to apply to graduate programs in neuroscience. Talk given at the Survival Skills and Ethics Workshop at the Society for Neuroscience Meeting, Washington, D.C., November 15. Dunbar, G.L. (2009). Use of mesenchymal stem cells for treating behavioral deficits in a rodent model of Huntington’s Disease. Talk given to American Society for Neural Therapy and Repair, Clearwater Beach, Florida, May 1. Dunbar, G. L. (2009). Use of Neurotrophic Factors to Reduce Behavioral Deficits in Rodent Models of Huntington’s Disease. Talk given at the Association for Psychological Science Festschrift in Honor of Donald Stein. San Francisco, California, May 25th. Dunbar, G.L. (2009). Adult stem cell therapy for Huntington’s Disease. Talk given to Huntington’s Disease Society of America, Michigan Chapter Meeting, Warren, Michigan, September 19. Dunbar, G.L. (2009). New developments in cellular therapies in rodent models of Huntington’s disease. Talk give to Institut Federatif de Rechereche Therapeutique de Nantes, Inserm, Universite de Nantes, Nantes, France, October 6. Dunbar, G.L. (2009). Use of adult stem cells for treating behavioral deficits in rodent models of Huntington’s disease. Talk given to the Saginaw County Medical Society, Saginaw, Michigan, October 20. Dunbar, G.L. (2010). Mesenchymal stem cell transplants reduce behavioral deficits in rodent models of Huntington’s disease. Invited talk at the 17th Annual Conference of the American Society for Neural Therapeutics and Repair, Clearwater Florida, April 30. Dunbar, G.L. (2010). Mesenchymal stem cell transplants reduce behavioral deficits in rodent models of Huntington’s disease. Invited talk at the HD2010 Meeting, Boston, Massachusetts, August 7. Dunbar, G.L. (2010). New Cellular therapies for treating Huntington’s disease. Invited talk to the Annual Meeting of the Huntington’s Disease Society of America, Michigan Chapter, Warren, Michigan, September 18. Dunbar, G.L. (2010). Sleep disorders in Huntington’s Disease patients. Invited talk given at the Fall Meeting of the Michigan Society of Electroneurodiagnostic Technologists, Saginaw, Michigan, September 24. Dunbar, G.L. (2010). Use of mesenchymal stem cells for treating behavioral deficits in rodent models of Huntington’s disease. Invited presentation at the World Stem Cell Summit, Detroit, Michigan, October 5. Dunbar, G.L., Weaver, C.L., Lowrance, S., and Matchynski, J.J. (2011). Experimental treatments for Alzheimer’s disease. Invited talk and panel presentation for the Alzheimer’s Disease Association of Michigan, Midland, Michigan, June 29. Dunbar, G.L. (2011). Pharmacological treatments in rodent models of Huntington’s disease. Invited talk for the School of Pharmacy Seminar, Ferris State University, Big Rapids, Michigan, June 30. Dunbar, G.L. (2011). Experimental treatments for cognitive and motor deficits in rodent models of Huntington’s disease. Invited talk for the Neuroscience Seminar Series at Grand Valley State University, Allendale, Michigan, September 14. Dunbar, G.L. (2011). Use of genetically-modified mesenchymal stem cells for treating cognitive and motor deficits in rodent models of Huntington;s disease. Invited talk for the Institute for Regenerative Cures Seminar, University of California, Davis, Sacramento, California, September 27. Dunbar, G.L. (2011). Use of adult stem cells for treating neurodegenerative disorders. Invited talk for the Feast of St. Luke Seminar, Alma Religious Sisters of Mercy, Alma, Michigan, October 18, 2011. Dunbar, G.L. (2012). Use of adult stem cells for treating cognitive and motor deficits in rodent models of Huntington’s disease. Biosciences Seminar, Western Michigan University, Kalamazoo, Michigan, February 17. Dunbar, G.L. (2012). Experimental therapies in rodent models of Huntington’s disease. Keynote address for Brain Awareness Week events at Delta College, University Center, Michigan, March 14. Dunbar, G.L. (2012). New developments in experimental therapies for Huntington’s disease. Keynote address for the Annual Conference of the Michigan Chapter of the Huntington’s Society of America, Warren, Michigan, September 15, 2012. Dunbar, G.L. and Field, E.M. (2012). New developments at Field Neurosciences Institute. Presentation for the Saginaw Valley Humanities Lecture Series, October 9, 2012. Dunbar, G.L., Field, E.M., Weaver, C.L., Matchynski, J.J., Song, M-S., Bradley, R., and Swihart, A. (2013). New research findings on causes and treatments for Alzheimer’s disease. Panel presentation and discussion at Field Neurosciences Institute Grand Rounds, Saginaw Michigan, January 17. Dunbar, G.L., and Rossignol, J. (2013). New developments in experimental therapies for Huntington’s disease. Invited talk at the Michigan Chapter of the Huntington’s Disease Society of America, Lansing, Michigan, March 1, 2014.

INTERVIEWS

WCMU-TV, Editor’s Notepad, Mt. Pleasant, Michigan, April 7, 1995 (Research on neurodegenerative disorders). WWTV/WWUP-TV, News, Cadillac, Michigan, March 20, 1997 (Research on Huntington’s disease) WJRT-TV, News, Flint, Michigan, September 30, 1997 (Research on Huntington’s disease) WWJ-radio, News, Detroit, Michigan, October 23, 1997 (Michigan Professor of the Year Award) WWTV/WWUP-TV, News, Cadillac, Michigan, October 24, 1997 (Michigan Professor of the Year Award) WYUR, News, Detroit, Michigan, October 24, 1997 (Michigan Professor of the Year Award) WCMU-TV, Editor’s Notepad, Mt. Pleasant, Michigan, November 7, 1997 (Michigan Professor of the Year Award) WCTV-3, Huntington’s Disease Update IV, Midland, Michigan, November 19, 1997 (Drug treatments for Huntington’s disease) WCMU-TV, Editor’s Notepad, Mt. Pleasant, Michigan, February 24, 1998 (Research on Huntington’s disease) WWTV/WWUP-TV, Central Connections: CMU in Northern Michigan, Cadillac, Michigan, July 15, 1998 (Research on Huntington’s disease) WCTV-3, Huntington’s Disease Update XIV-XV, Midland, Michigan, December 2, 1998 (Drug treatments for Huntington’s disease) Interview excerpts and research featured in: Tamplia, Lorra (1999). Living with Huntington’s disease. Disability Life, November, pp 38-42. WOOD-Radio (2001). Use of stem cells in research. March 13, 2001. Interview for Development and Alumni Relations (2003). A new vision of excellence: the campaign for Central Michigan University. Midland News. Need for heroes. February 18, 2004. Saginaw News. Technology in the new Health Professions Building. March 5, 2004. WCMU-TV, Inside Central. Faculty for Undergraduate Neuroscience lifetime achievement award. March, 9, 2004. Mt. Pleasant Morning Sun. Benefits of the New Health Professions Building for the neuroscience program at Central Michigan University. March 26, 2004. WCMU Radio. Interview on use of stem cells to treat neurodegenerative diseases. September 2, 2005. WTOM TV7/4. Interview on testing Cerise Nutraceutical product. Traverse City, Michigan, November 13, 2006. WTCM Radio. Interview on testing Cerise Nutraceutical product. December 14, 2006. Cadillac Evening News. Interview on use of stem cells for therapeutic research. Cadillac, Michigan, April 17, 2007. Cadillac Evening News. Interview on stem cells. Cadillac, Michigan, August 24, 2007. WZZM TV13. Interview on stem cells. Grand Rapids, Michigan, October 24, 2007. Battle Creek Enquirer. Interview on stem cells. Albion, Michigan, February 20, 2008. Jackson Citizen Patriot. Interview on stem cells. Albion, Michigan, February 20, 2008. WTCM Radio. Interview about testing Cerise Nutraceutical product. June 23, 2008. WNEM-TV5 interview about collaborative stem cell research with students from France at CMU, Mt. Pleasant, Michigan, August 26, 2008. MLive. News story “CMU prof to lead Field Neurosciences Institute”, September 4, 2008. WNEM-TV 5 interview on Proposition 2, Saginaw, Michigan, November 4. Saginaw News. Inteview for news story “Proposal 2 passage brings joy for some, concern for others”, November 10, 2008. Saginaw News interview about research and teaching, Saginaw, Michigan, December 10, 2008. WJRT-TV12 interview on lead contamination and neurological consequences. Flint, Michigan, February 19, 2009. WNEM-TV 5 interview on fundraiser for flow cytometer, September 18, 2009. WJR radio interview on ruling to halt funding for embryonic stem cell research, August 25, 2010. WNEM-TV5 interview about research at the FNI labs, August 25, 2010. WDCQ radio interview about research and fundraising for FNI labs, September 13, 2010. Saginaw News interview for story, “Saginaw Township’s Field Neurosciences Institute exploration is on the edge”, September 21, 2010. Saginaw News interview for story, “Community comes together in a big way at the Temple Theatre for the Field Neurosciences Institute”, September 25, 2010. Saginaw News interview about stem cell research at FNI labs, September 30, 2010. WLCQ/WSAM interview about adult stem cell research at FNI labs, September 22. 2010. Saginaw News interview for story, “Dunbar receives President’s Award from CMU”, April 18, 2011. Q-90.1 WUCX (PBS) radio interview on research and educational program at Field Neurosciences Institute, Saginaw, Michigan, September 12, 2011. TV 25 Interview on research and educational programs at Field Neurosciences Institute, Clio, Michigan, September 13, 2011. TV 5 Interview on research and educational programs at Field Neurosciences Institute, Saginaw, Michigan, September 13, 2011. Saginaw News interview for story, “Field of Hope BennettFit for Field Neurosciences Institute set for September 23”, September 18, 2011. WSAM radio interview on research and educational program at Field Neurosciences Institute, Saginaw, Michigan, September 20, 2011 WSGW radio interview on research and educational program at Field Neurosciences Institute, Saginaw, Michigan, September 22, 2011. Saginaw News interview for story, “FNI broke a lot of new ground Friday at Saginaw’s Field of Hope BennettFit”, September 24, 2011. Embrace of Aging interview about research on neurodegenerative diseases at Central Michigan University, Mt. Pleasant, Michigan, November 4, 2011. Saginaw News interview for story, “Delta College celebrating Brain Awareness Week with variety of events”, March 12, 2012. Midland News interview on adult stem cell research, Saginaw, Michigan, June 25, 2012. WTCM Radio. Interview about use Cerise Total Body Rhythm for treating neurodegenerative disorders, July 10, 2012. Q90.1 Radio interview about research and service programs offered by Field Neurosciences Institute, Delta College, University Center, Michigan, August 5, 2012. WSGW Radio interview about adult stem cell research, Saginaw, Michigan, August 16, 2012. WSAM Radio interview about adult stem cell research. Saginaw, Michigan, August 17, 2012. Saginaw News interview for story, “Saginaw Valley Humanities series marches through time with new season, August 22, 2012. Saginaw News interview for story, “Saginaw’s gala’s true star is the work done at Field Neurosciences Institute”, September 3, 2012. WJRT TV-12 interview about research and service programs offered by Field Neurosciences Institute, September 4, 2012. WNEM TV-5 interview about research and service programs offered by Field Neurosciences Institute, September 6, 2012. WKCQ Radio interview about programs offered by Field Neurosciences Institute, September 10, 2012. Saginaw News interview for story, “A record crowd celebrates FNI in grand style at Saginaw’s Temple Theatre, September 15, 2012. WDCQ TV19 Interviewed by Dave Oppermann on “Celebrity Corner” about stem cell research at the Field Neurosciences Institute, Saginaw, Michigan, October 9, 2012. Detroit Free Press interview for story, “Stem cell’s promise hits funding wall in Michigan”, November 18, 2012. WDCQ TV19 (PBS). Interview about stem cell research, Saginaw, Michigan, April 27, 2013. CBS Detroit interview with Matt Roush on “Cherry Compounds Show Promising Results in Alzheimer’s Test, April 24, 2013. USA Today and Detroit Free Press interview by Paul Egan, “Scientists say tart fruit’s antioxidants could reduce symptoms of Alzheimer’s and Huntington’s”, January 13, 2014.